☰

Erik P. Sulman, M.D./Ph.D. - Publications

Affiliations: 
Radiation Oncology UT MDAnderson Cancer Center 
Area:
Glioblastoma Tumor Initiating Cells
Tree Info Grants Similar researchers PubMed Report error

216/400 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Nuechterlein N, Shelbourn A, Szulzewsky F, Arora S, Casad M, Pattwell S, Merino-Galan L, Sulman E, Arowa S, Alvinez N, Jung M, Brown D, Tang K, Jackson S, Stoica S, et al. Haploinsufficiency of phosphodiesterase 10A activates PI3K/AKT signaling independent of PTEN to induce an aggressive glioma phenotype. Genes & Development. PMID 38589034 DOI: 10.1101/gad.351350.123  0.315
2022 Modrek AS, Eskilsson E, Ezhilarasan R, Wang Q, Goodman LD, Ding Y, Zhang ZY, Bhat KPL, Le TT, Barthel FP, Tang M, Yang J, Long L, Gumin J, Lang FF, ... ... Sulman EP, et al. PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells. Frontiers in Oncology. 12: 941657. PMID 36059614 DOI: 10.3389/fonc.2022.941657  0.746
2022 Stitzlein L, Gangadharan A, Grasse L, Espejo A, Singh M, Lu Y, Ezhilarasan R, Gumin J, Sulman E, Lang F, Chandra J. Evaluation of in vitro and in vivo efficacy of pharmacological lysine-specific demethylase 1 (LSD1) inhibitors in glioblastoma stem cell (GSC) models. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 35554689 DOI: 10.1096/fasebj.2022.36.S1.0R249  0.336
2021 Huang T, Yang Y, Song X, Wan X, Wu B, Sastry N, Horbinski CM, Zeng C, Tiek D, Goenka A, Liu F, Brennan CW, Kessler JA, Stupp R, Nakano I, ... Sulman EP, et al. PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cells. Molecular Cell. PMID 33539787 DOI: 10.1016/j.molcel.2021.01.015  0.32
2020 Cui X, Ma C, Vasudevaraja V, Serrano J, Tong J, Peng Y, Delorenzo M, Shen G, Frenster J, Morales RT, Qian W, Tsirigos A, Chi AS, Jain R, Kurz SC, ... Sulman EP, et al. Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy. Elife. 9. PMID 32909947 DOI: 10.7554/Elife.52253  0.336
2020 Sa JK, Chang N, Lee HW, Cho HJ, Ceccarelli M, Cerulo L, Yin J, Kim SS, Caruso FP, Lee M, Kim D, Oh YT, Lee Y, Her NG, Min B, ... ... Sulman EP, et al. Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma. Genome Biology. 21: 216. PMID 32847614 DOI: 10.1186/S13059-020-02140-X  0.397
2020 Mohan R, Liu AY, Brown PD, Mahajan A, Dinh J, Chung C, McAvoy S, McAleer MF, Lin SH, Li J, Ghia AJ, Zhu C, Sulman EP, de Groot JF, Heimberger AB, et al. Proton Therapy Reduces the Likelihood of High-Grade Radiation-Induced Lymphopenia in Glioblastoma Patients: Phase II Randomized Study of Protons vs. Photons. Neuro-Oncology. PMID 32750703 DOI: 10.1093/Neuonc/Noaa182  0.318
2020 Vougiouklakis T, Aung PP, Vasudevaraja V, Prieto VG, Torres-Cabala CA, Sulman EP, Snuderl M, Jour G. Correlative study of epigenetic regulation of tumor microenvironment in spindle cell melanomas and cutaneous malignant peripheral nerve sheath tumors. Scientific Reports. 10: 12996. PMID 32747660 DOI: 10.1038/S41598-020-69787-1  0.391
2020 Chen Z, Herting CJ, Ross JL, Gabanic B, Puigdelloses Vallcorba M, Szulzewsky F, Wojciechowicz ML, Cimino PJ, Ezhilarasan R, Sulman EP, Ying M, Ma'ayan A, Read RD, Hambardzumyan D. Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade. Glia. PMID 32639068 DOI: 10.1002/Glia.23883  0.379
2020 Liu EK, Yu S, Sulman EP, Kurz SC. Racial and socioeconomic disparities differentially affect overall and cause-specific survival in glioblastoma. Journal of Neuro-Oncology. PMID 32617722 DOI: 10.1007/S11060-020-03572-Y  0.32
2020 Ott M, Kassab C, Marisetty A, Hashimoto Y, Wei J, Zamler DB, Leu JS, Tomaszowski KH, Sabbagh A, Fang D, Gupta P, Priebe W, Zielinski R, Burks JK, Long JP, ... ... Sulman EP, et al. Radiation with STAT3 blockade triggers dendritic cell-T cell interactions in the glioma microenvironment and therapeutic efficacy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32605912 DOI: 10.1158/1078-0432.Ccr-19-4092  0.399
2020 Liu EK, Silverman JS, Sulman EP. Stereotactic Radiation for Treating Primary and Metastatic Neoplasms of the Spinal Cord. Frontiers in Oncology. 10: 907. PMID 32582555 DOI: 10.3389/Fonc.2020.00907  0.317
2020 Liu EK, Sulman EP, Wen PY, Kurz SC. Novel Therapies for Glioblastoma. Current Neurology and Neuroscience Reports. 20: 19. PMID 32445058 DOI: 10.1007/S11910-020-01042-6  0.369
2020 Buxton MB, Alexander BM, Berry DA, Cavenee WK, Colman H, Groot JFD, Ellingson BM, Gordon GB, Khasraw M, Lassman AB, Li W, Lim M, Mellinghoff IK, Perry JR, Sulman EP, et al. GBM AGILE: A global, phase II/III adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps2579  0.365
2020 Liu E, Oh C, Sulman EP. Relative and absolute risk of second primary neoplasms of the central nervous system. Journal of Clinical Oncology. 38: 1593-1593. DOI: 10.1200/Jco.2020.38.15_Suppl.1593  0.305
2020 Rahal O, Yang J, Li L, Larson R, Laere SV, Ueno N, Sulman E, Woodward W. Abstract P6-06-08: Transcriptome analysis of patient derived xenograft mouse models of inflammatory breast cancer to gain insights into the contribution of tumor microenvironment Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P6-06-08  0.357
2019 Pradhan D, Jour G, Milton D, Vasudevaraja V, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Long L, Ding Y, Ezhilarasan R, Sulman EP, Diab A, Hwu WJ, Prieto VG, et al. Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma. Cancers. 11. PMID 31888295 DOI: 10.3390/Cancers11122031  0.347
2019 Wu S, Gao F, Zheng S, Zhang C, Martinez-Ledesma E, Ezhilarasan R, Ding J, Li X, Feng N, Multani A, Sulman EP, Verhaak RG, de Groot JF, Heffernan TP, Yung WKA, et al. EGFR amplification induces increased DNA damage response and renders selective sensitivity to Talazoparib (PARP inhibitor) in glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31852834 DOI: 10.1158/1078-0432.Ccr-19-2549  0.316
2019 Vaubel RA, Tian S, Remonde D, Schroeder MA, Mladek AC, Kitange GJ, Caron A, Kollmeyer TM, Grove R, Peng S, Carlson BL, Ma DJ, Sarkar G, Evers L, Decker PA, ... ... Sulman EP, et al. Genomic and phenotypic characterization of a broad panel of patient derived xenografts reflects the diversity of glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31852831 DOI: 10.1158/1078-0432.Ccr-19-0909  0.392
2019 Ma J, Benitez JA, Li J, Miki S, Ponte de Albuquerque C, Galatro T, Orellana L, Zanca C, Reed R, Boyer A, Koga T, Varki NM, Fenton TR, Nagahashi Marie SK, Lindahl E, ... ... Sulman EP, et al. Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair. Cancer Cell. 36: 690-691. PMID 31821785 DOI: 10.1016/J.Ccell.2019.11.008  0.31
2019 Bledea R, Vasudevaraja V, Patel S, Stafford J, Serrano J, Esposito G, Tredwin LM, Goodman N, Kloetgen A, Golfinos JG, Zagzag D, Weigelt B, Iafrate AJ, Sulman EP, Chi AS, et al. Functional and topographic effects on DNA methylation in IDH1/2 mutant cancers. Scientific Reports. 9: 16830. PMID 31727977 DOI: 10.1038/S41598-019-53262-7  0.317
2019 Yang Y, Dodbele S, Park T, Glass R, Bhat K, Sulman EP, Zhang Y, Abounader R. MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway. Journal of Neuro-Oncology. PMID 31482267 DOI: 10.1007/S11060-019-03275-Z  0.306
2019 Gates EDH, Yang J, Fukumura K, Lin JS, Weinberg JS, Prabhu SS, Long L, Fuentes D, Sulman EP, Huse JT, Schellingerhout D. Spatial Distance Correlates With Genetic Distance in Diffuse Glioma. Frontiers in Oncology. 9: 676. PMID 31417865 DOI: 10.3389/Fonc.2019.00676  0.371
2019 Burgenske DM, Yang J, Decker PA, Kollmeyer TM, Kosel ML, Mladek AC, Caron AA, Vaubel RA, Gupta SK, Kitange GJ, Sicotte H, Youland RS, Remonde D, Voss JS, Fritcher EGB, ... ... Sulman EP, et al. Molecular Profiling of Long-Term IDH-wildtype Glioblastoma Survivors. Neuro-Oncology. PMID 31346613 DOI: 10.1093/Neuonc/Noz129  0.323
2019 Farooqi A, Yang J, Sharin V, Ezhilarasan R, Danussi C, Alvarez C, Dharmaiah S, Irvin D, Huse J, Sulman EP. Identification of patient-derived glioblastoma stem cell (GSC) lines with the alternative lengthening of telomeres phenotype. Acta Neuropathologica Communications. 7: 76. PMID 31097032 DOI: 10.1186/S40478-019-0732-4  0.346
2019 Ma J, Benitez JA, Li J, Miki S, Ponte de Albuquerque C, Galatro T, Orellana L, Zanca C, Reed R, Boyer A, Koga T, Varki NM, Fenton TR, Nagahashi Marie SK, Lindahl E, ... ... Sulman EP, et al. Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair. Cancer Cell. PMID 30827889 DOI: 10.1016/J.Ccell.2019.01.020  0.386
2019 Wang Y, Yang J, Wild AT, Wu WH, Shah R, Danussi C, Riggins GJ, Kannan K, Sulman EP, Chan TA, Huse JT. G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma. Nature Communications. 10: 943. PMID 30808951 DOI: 10.1038/S41467-019-08905-8  0.327
2019 Minata M, Audia A, Shi J, Lu S, Bernstock J, Pavlyukov MS, Das A, Kim SH, Shin YJ, Lee Y, Koo H, Snigdha K, Waghmare I, Guo X, Mohyeldin A, ... ... Sulman EP, et al. Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation. Cell Reports. 26: 1893-1905.e7. PMID 30759398 DOI: 10.1016/J.Celrep.2019.01.076  0.41
2019 Chumakova AP, Hitomi M, Sulman EP, Lathia JD. High-throughput automated single-cell imaging analysis reveals dynamics of glioblastoma stem cell population during state transition. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. PMID 30729665 DOI: 10.1002/Cyto.A.23728  0.377
2019 Yeboa DN, Yu JB, Liao E, Huse J, Penas-Prado M, Kann BH, Sulman E, Grosshans D, Contessa J. Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas. Clinical and Translational Radiation Oncology. 15: 46-52. PMID 30656222 DOI: 10.1016/J.Ctro.2018.12.003  0.366
2019 Huang T, Wan X, Alvarez AA, James CD, Song X, Yang Y, Sastry N, Nakano I, Sulman EP, Hu B, Cheng SY. MIR93 (microRNA -93) Regulates Tumorigenicity and Therapy Response of Glioblastoma by Targeting Autophagy. Autophagy. PMID 30654687 DOI: 10.1080/15548627.2019.1569947  0.342
2019 Yung WKA, Wu S, Gao F, Zheng S, Ding J, Zhang C, Li X, Ezhilarasan R, Feng N, De Groot JF, Sulman EP, Heffernan T, Koul D. EGFR amplification predicted selective sensitivity to PARP inhibitors with high PARP-DNA trapping potential in human GBM. Journal of Clinical Oncology. 37: 2047-2047. DOI: 10.1200/Jco.2019.37.15_Suppl.2047  0.333
2019 Park SY, Piao Y, Martinez-Ledesma E, Dong J, Khan S, Mittal S, Zhang Z, Sulman EP, Balasubramaniyan V, Groot JFd. Abstract 4678: Targeting MEK in EGFR amplified glioma stem like cells induces differentiation Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-4678  0.345
2019 Lee W, Gomez D, Zhang J, Reuben A, Jalali A, Roh W, Wu CC, Lu W, Chow C, Fujimoto J, Antonoff M, Moran C, Sulman E, Rao G, Swisher S, et al. Abstract 2741: Comprehensive molecular profiling of primary tumors and paired distant metastases in non-small cell lung cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2741  0.354
2019 Zhang Z, Ding Y, Ezhilarasan R, Yang J, Long L, Bronk L, Wang Q, Sulman EP. Abstract 1917: High-throughput evaluation of treatment response in patient-derived glioma stem cell models Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-1917  0.358
2019 Zhang Z, Ezhilarasan R, Ding Y, Wang Q, Yang J, Long L, Verhaak RG, Sulman EP. Abstract 4698: Development of a CRISPR-Cas9D10Atargetable, high-complexity, single-cell barcoding approach for capture of treatment resistant subclones from heterogeneous cancers Cancer Research. 79: 4698-4698. DOI: 10.1158/1538-7445.Am2019-4698  0.375
2019 Yang J, Wang Q, Ezhilarasan R, Long L, Wiestler B, Wick W, Miao Y, Sulman E. Abstract 4238: DNA-methylation based epigenetic signatures predict and deconvolute somatic genomic alterations in gliomas Cancer Research. 79: 4238-4238. DOI: 10.1158/1538-7445.Am2019-4238  0.406
2019 Fukumura K, Mao X, Song X, Fischer GM, Yang J, Sulman EP, Davies MA, Zhang J, Huse JT. Abstract 3406: Comprehensive genomic analysis of brain metastases from multiple cancer types Cancer Research. 79: 3406-3406. DOI: 10.1158/1538-7445.Am2019-3406  0.37
2019 McGovern S, Luo D, Johnson M, Nguyen K, Li J, McAleer M, Yeboa D, Grosshans D, Ghia A, Chung C, Thall P, Sulman E, Brown P, Mahajan A. RTHP-23. PROSPECTIVE TRIAL OF CONVENTIONALLY FRACTIONATED DOSE CONSTRAINTS FOR RE-IRRADIATION OF PRIMARY BRAIN TUMORS Neuro-Oncology. 21: vi214-vi214. DOI: 10.1093/Neuonc/Noz175.894  0.357
2019 Al Feghali K, Randall J, Wefel J, Guha-Thakurta N, Grosshans D, Dibaj S, McAvoy S, Li J, McGovern S, McAleer M, Ghia A, Paulino A, Sulman E, Penas-Prado M, Wang J, et al. NIMG-03. PROSPECTIVE PHASE II RANDOMIZED TRIAL COMPARING PROTON THERAPY VS. PHOTON IMRT FOR GBM: SECONDARY ANALYSIS COMPARISON OF PROGRESSION FREE SURVIVAL BETWEEN RANO VS. CLINICAL AND RADIOLOGICAL ASSESSMENT Neuro-Oncology. 21: vi161-vi162. DOI: 10.1093/Neuonc/Noz175.675  0.353
2019 Balasubramaniyan V, Park S, Piao Y, Martínez E, Dong J, Mittal S, Khan S, Zhang Z, Sulman E, DeGroot J. Ddis-32. Mek Inhibitors Induces Neuronal Differentiation In Egfr Amplified Glioma Stem Like Cells Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.283  0.316
2019 Arrillaga-Romany I, Kurz S, Sumrall A, Butowski N, Harrison R, DeGroot J, Chi A, Sulman E, Shonka N, Umemura Y, Odia Y, Mehta M, Iwamoto F, Leia Nghiemphu P, Cloughesy T, et al. ACTR-34. SINGLE AGENT ONC201 IN PREVIOUSLY-TREATED, PROGRESSIVE ADULT H3 K27M-MUTANT GLIOMA Neuro-Oncology. 21: vi20-vi21. DOI: 10.1093/Neuonc/Noz175.077  0.325
2018 Olar A, Tran D, Mehta VP, Reinhardt A, Manekia JH, Garnovskaya M, Ellezam B, Luthra R, Sulman EP, Mohila CA, Campbell GA, Powell SZ, Fuller GN, Aldape KD, Adesina AM. ATRX protein loss and deregulation of PI3K/AKT pathway is frequent in pilocytic astrocytoma with anaplastic features. Clinical Neuropathology. PMID 30499772 DOI: 10.5414/Np301105  0.323
2018 Spino M, Kurz SC, Chiriboga L, Serrano J, Zeck B, Sen N, Patel S, Shen G, Vasudevaraja V, Tsirigos A, Suryadevara CM, Frenster JD, Tateishi K, Wakimoto H, Jain R, ... ... Sulman EP, et al. Cell surface Notch ligand DLL3 is a therapeutic target in isocitrate dehydrogenase mutant glioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30397180 DOI: 10.1158/1078-0432.Ccr-18-2312  0.336
2018 Jour G, Vasudevaraja V, Prieto VG, Snuderl M, Torres-Cabala CA, Al-Rohil R, Sulman EP, Ballester LY, Aung PP. BCAT1 and miR-2504: novel methylome signature distinguishes spindle/desmoplastic melanoma from superficial malignant peripheral nerve sheath tumor. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 30310175 DOI: 10.1038/S41379-018-0146-Z  0.354
2018 Yuan AL, Ricks CB, Bohm AK, Lun X, Maxwell L, Safdar S, Bukhari S, Gerber A, Sayeed W, Bering EA, Pedersen H, Chan JA, Shen Y, Marra M, Kaplan DR, ... ... Sulman EP, et al. ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts. Plos One. 13: e0202860. PMID 30153289 DOI: 10.1371/Journal.Pone.0202860  0.707
2018 Latha K, Yan J, Yang Y, Gressot LV, Kong LY, Manyam G, Ezhilarasan R, Wang Q, Sulman EP, Eric Davis R, Huang S, Fuller GN, Rao A, Heimberger AB, Li S, et al. The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma. Journal of the National Cancer Institute. PMID 29947810 DOI: 10.1093/Jnci/Djy107  0.406
2018 Pietanza MC, Waqar SN, Krug LM, Dowlati A, Hann CL, Chiappori A, Owonikoko TK, Woo KM, Cardnell RJ, Fujimoto J, Long L, Diao L, Wang J, Bensman Y, Hurtado B, ... ... Sulman EP, et al. Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018777672. PMID 29906251 DOI: 10.1200/Jco.2018.77.7672  0.351
2018 Olar A, Goodman LD, Wani KM, Boehling NS, Sharma DS, Mody RR, Gumin J, Claus EB, Lang FF, Cloughesy TF, Lai A, Aldape KD, DeMonte F, Sulman EP. A gene expression signature predicts recurrence-free survival in meningioma. Oncotarget. 9: 16087-16098. PMID 29662628 DOI: 10.18632/Oncotarget.24498  0.727
2018 Gabrusiewicz K, Li X, Wei J, Hashimoto Y, Marisetty AL, Ott M, Wang F, Hawke D, Yu J, Healy LM, Hossain A, Akers JC, Maiti SN, Yamashita S, Shimizu Y, ... ... Sulman EP, et al. Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes. Oncoimmunology. 7: e1412909. PMID 29632728 DOI: 10.1080/2162402X.2017.1412909  0.316
2018 Dong J, Park SY, Nguyen N, Ezhilarasan R, Martinez-Ledesma E, Wu S, Henry V, Piao Y, Tiao N, Brunell D, Stephan C, Verhaak R, Sulman E, Balasubramaniyan V, de Groot JF. The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells. Oncotarget. 9: 10497-10509. PMID 29535822 DOI: 10.18632/Oncotarget.24041  0.398
2018 Danussi C, Bose P, Parthasarathy PT, Silberman PC, Van Arnam JS, Vitucci M, Tang OY, Heguy A, Wang Y, Chan TA, Riggins GJ, Sulman EP, Lang F, Creighton CJ, Deneen B, et al. Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling. Nature Communications. 9: 1057. PMID 29535300 DOI: 10.1038/S41467-018-03476-6  0.39
2018 Aldape K, Amin SB, Ashley DM, Barnholtz-Sloan JS, Bates AJ, Beroukhim R, Bock C, Brat DJ, Claus EB, Costello JF, de Groot JF, Finocchiaro G, French PJ, Gan HK, Griffith B, ... ... Sulman EP, et al. Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium. Neuro-Oncology. PMID 29432615 DOI: 10.1093/Neuonc/Noy020  0.379
2018 Luedi MM, Singh SK, Mosley JC, Hassan ISA, Hatami M, Gumin J, Andereggen L, Sulman EP, Lang FF, Stueber F, Fuller GN, Colen RR, Zinn PO. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma. Journal of Neurosurgery. 1-10. PMID 29328002 DOI: 10.3171/2017.7.Jns17668  0.453
2018 Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel F, Cho HJ, Lin YH, Satani N, Martinez-Ledesma E, ... ... Sulman EP, et al. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell. 33: 152. PMID 29316430 DOI: 10.1016/J.Ccell.2017.12.012  0.395
2018 Wefel JS, Deshmukh S, Brown PD, Grosshans DR, Sulman EP, Cerhan JH, Mehta MP, Khuntia D, Shi W, Mishra MV, Suh JH, Laack NN, Chen Y, Curtis A, Laba J, et al. Impact of apolipoprotein E (APOE) genotype on neurocognitive function (NCF) in patients with brain metastasis (BM): An analysis of NRG Oncology’s RTOG 0614. Journal of Clinical Oncology. 36: 2065-2065. DOI: 10.1200/Jco.2018.36.15_Suppl.2065  0.322
2018 Maraka S, Groves MD, Mammoser AG, Melguizo-Gavilanes I, Conrad CA, Tremont-Lukats I, Loghin ME, O'Brien BJ, Puduvalli VK, Sulman EP, Hess KR, Aldape KD, Gilbert MR, De Groot JF, Yung WKA, et al. Phase I factorial study of temozolomide plus memantine, mefloquine, and metformin as post-radiation adjuvant therapy for newly diagnosed glioblastoma. Journal of Clinical Oncology. 36: 2044-2044. DOI: 10.1200/Jco.2018.36.15_Suppl.2044  0.324
2018 Shaw V, Piao Y, Park SY, Dong J, Martinez-Ledesma E, Carrillo C, Henry V, Ezhilarasan R, Sulman E, Balasubramaniyan V, Groot JFd. Abstract 4858: Efficacy of the protein arginine methyltransferase PRMT5 inhibitor GSK591 in glioma stem-like cells Cancer Research. 78: 4858-4858. DOI: 10.1158/1538-7445.Am2018-4858  0.423
2018 Dong J, Martinez-Ledesma E, Nguyen N, Wu S, Piao Y, Tiao N, Park SY, Brunell D, Stephan C, Verhaak R, Sulman E, Balasubramaniyan V, Groot JFd. Abstract 4819: High-throughput screening of glioma stem-like cells (GSCs) identifies synergistic therapeutic combination of FGFR inhibitor and CDK4/6 inhibitor Cancer Research. 78: 4819-4819. DOI: 10.1158/1538-7445.Am2018-4819  0.374
2018 Johnson KC, Barthel FP, Tang M, Amin S, Wang Q, Sulman EP, Rai K, Verhaak RGW. Abstract 4355: Identification and functional characterization of glioma structural variants Cancer Research. 78: 4355-4355. DOI: 10.1158/1538-7445.Am2018-4355  0.411
2018 Hossain MB, Shifat R, Kim DK, Rivera-Molina Y, Martinez FP, Jiang H, Nguyen T, Johnson DG, Bedford MT, Hung M, Sulman EP, Lang F, Sawaya R, Fueyo J, Gomez-Manzano C. Abstract 3205: Histone tyrosine phosphorylation determines glioblastoma cell survival Cancer Research. 78: 3205-3205. DOI: 10.1158/1538-7445.Am2018-3205  0.382
2018 Dong J, Martinez-Ledesma E, Nguyen N, Carrillo C, Piao Y, Henry V, Park SY, Tiao N, Stephan C, Verhaak R, Sulman E, Balasubramaniyan V, Groot JFd. Abstract 2945: Arsenic trioxide sensitizes glioma stem cells to brain penetrant PI3K and mTOR inhibitor GDC-0084 Cancer Research. 78: 2945-2945. DOI: 10.1158/1538-7445.Am2018-2945  0.407
2018 Huang T, Kim CK, Alvarez AA, Pangeni RP, Wan X, song x, shi T, Yongyong Y, Sastry N, Horbinski C, Lu S, Stupp R, Kessler J, Nishikawa R, Nakano I, ... Sulman E, et al. Abstract 1122: MST4 phosphorylation of ATG4B regulates autophagic activity, tumorigenicity, and radio resistance in glioblastoma Cancer Research. 78: 1122-1122. DOI: 10.1158/1538-7445.Am2018-1122  0.417
2018 Zinn PO, Singh SK, Kotrotsou A, Hassan I, Luedi MM, Thomas G, Elshafeey N, Mosley J, Elakkad A, Idris T, Gumin J, Fuller GN, de Groot J, Baladandayuthapani V, Sulman EP, et al. 100 Toward the Co-clinical Glioblastoma Treatment Paradigm—Radiomic Machine Learning Identifies Glioblastoma Gene Expression in Patients and Corresponding Xenograft Tumor Models Neurosurgery. 65: 80-80. DOI: 10.1093/Neuros/Nyy303.100  0.359
2018 Bronk L, Ezhilarasan R, Ding Y, Zhang Z, Sulman E. Rdna-02. Tumor Treating Fields Differentially Alter Homologous Recombination In Patient Derived Glioma Cells Versus Established Lines Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.918  0.41
2018 Mittal S, Shaw V, Piao Y, Park SY, Sriram S, Dong J, Martinez-Ledesma E, Henry V, Ezhilarasan R, Sulman E, Balasubramaniyan V, Groot Jd. Exth-12. Effect Of The Protein Arginine Methyltransferase Prmt5 Inhibition In Glioma Stem-Like Cells Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.361  0.338
2018 Wu S, Gao F, Zheng S, Zhang C, Martinez-Ledesma JE, Ezhilarasan R, Ding J, Li X, Feng N, Sulman E, Verhaak R, Groot Jd, Heffernan T, Yung WKA, Koul D. Ddis-03. Egfr Amplification Induced Increased Dna Damage Response And Predicted Selective Sensitivity To Talazoparib (Parp Inhibitor) In Glioblastoma Stem-Like Cells Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.282  0.333
2018 Vaubel R, Tian S, Remonde D, Schroeder M, Kollmeyer T, Peng S, Mladek A, Carlson B, Ma D, Kitange G, Evers L, Decker P, Kosel M, Berens M, Klee E, ... ... Sulman E, et al. TMOD-18. THE PATIENT DERIVED XENOGRAFT NATIONAL RESOURCE: A COMPREHENSIVE COLLECTION OF HIGH-GRADE GLIOMA MODELS FOR PRE-CLINICAL AND TRANSLATIONAL STUDIES Neuro-Oncology. 20: vi272-vi272. DOI: 10.1093/Neuonc/Noy148.1130  0.308
2018 Rao G, Latha K, Yan J, Yang Y, Manyam G, Ezhilarasan R, Sulman E, Rao A, Heimberger A, Li S. TMIC-33. THE ROLE OF FIBRINOGEN-LIKE PROTEIN 2 ON IMMUNOSUPPRESSION AND MALIGNANT PROGRESSION IN GLIOMA Neuro-Oncology. 20: vi263-vi263. DOI: 10.1093/Neuonc/Noy148.1092  0.303
2018 Farooqi A, Yang J, Sharin V, Huse JT, Sulman E. Stem-05. Identification Of Patient-Derived Glioblastoma Stem Cell (Gsc) Lines With The Alternative Lengthening Of Telomeres Phenotype Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.1012  0.334
2017 Mostovenko E, Végvári Á, Rezeli M, Lichti CF, Fenyö D, Wang Q, Lang FF, Sulman EP, Sahlin KB, Marko-Varga G, Nilsson CL. Large Scale Identification of Variant Proteins in Glioma Stem Cells. Acs Chemical Neuroscience. PMID 29254333 DOI: 10.1021/Acschemneuro.7B00362  0.464
2017 Huang T, Kim CK, Alvarez AA, Pangeni RP, Wan X, Song X, Shi T, Yang Y, Sastry N, Horbinski CM, Lu S, Stupp R, Kessler JA, Nishikawa R, Nakano I, ... Sulman EP, et al. MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma. Cancer Cell. 32: 840-855.e8. PMID 29232556 DOI: 10.1016/J.Ccell.2017.11.005  0.387
2017 Fang P, Boehling NS, Koay EJ, Bucheit AD, Jakob JA, Settle SH, Brown PD, Davies MA, Sulman EP. Melanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy. Journal of Neuro-Oncology. PMID 29198052 DOI: 10.1007/S11060-017-2695-2  0.312
2017 Moreno M, Pedrosa L, Paré L, Pineda E, Bejarano L, Martínez J, Balasubramaniyan V, Ezhilarasan R, Kallarackal N, Kim SH, Wang J, Audia A, Conroy S, Marin M, Ribalta T, ... ... Sulman EP, et al. GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma. Cell Reports. 21: 2183-2197. PMID 29166609 DOI: 10.1016/J.Celrep.2017.10.083  0.4
2017 Boonyawan K, Hess KR, Yang J, Long L, Wang Q, Ezhilarasan R, Auia A, Alfaro-Munoz KD, de Groot JF, Bhat KP, Sulman EP. A relative increase in circulating platelets following chemoradiation predicts for poor survival of patients with glioblastoma. Oncotarget. 8: 90488-90495. PMID 29163847 DOI: 10.18632/Oncotarget.21799  0.343
2017 Ong DST, Hu B, Ho YW, Sauvé CG, Bristow CA, Wang Q, Multani AS, Chen P, Nezi L, Jiang S, Gorman CE, Monasterio MM, Koul D, Marchesini M, Colla S, ... ... Sulman EP, et al. PAF promotes stemness and radioresistance of glioma stem cells. Proceedings of the National Academy of Sciences of the United States of America. 114: E9086-E9095. PMID 29073105 DOI: 10.1073/Pnas.1708122114  0.409
2017 An Y, Jiang W, Kim BYS, Qian JM, Tang C, Fang P, Logan J, D'Souza NM, Haydu LE, Wang XA, Hess KR, Kluger H, Glitza IC, Mahajan A, Welsh JW, ... ... Sulman EP, et al. Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTL-4 treatment is associated with improved intracranial control. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28916225 DOI: 10.1016/J.Radonc.2017.08.009  0.333
2017 Li M, Xiao A, Floyd D, Olmez I, Lee J, Godlewski J, Bronisz A, Bhat KPL, Sulman EP, Nakano I, Purow B. CDK4/6 inhibition is more active against the glioblastoma proneural subtype. Oncotarget. 8: 55319-55331. PMID 28903422 DOI: 10.18632/Oncotarget.19429  0.435
2017 Wang Y, Wu S, Zheng S, Wang S, Wali A, Ezhilarasan R, Sulman EP, Koul D, Alfred Yung WK. APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death. Oncotarget. 8: 54285-54296. PMID 28903341 DOI: 10.18632/Oncotarget.17348  0.441
2017 Guerrero PA, Tchaicha JH, Chen Z, Morales JE, McCarty N, Wang Q, Sulman EP, Fuller G, Lang FF, Rao G, McCarty JH. Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression. Oncogene. PMID 28783169 DOI: 10.1038/Onc.2017.248  0.453
2017 Li M, Xiao A, Floyd D, Olmez I, Lee J, Godlewski J, Bronisz A, Bhat KPL, Sulman EP, Nakano I, Purow B. CDK4/6 inhibition is more active against the glioblastoma proneural subtype. Oncotarget. PMID 28751617 DOI: 10.18632/oncotarget.19429  0.325
2017 Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel F, Cho HJ, Lin YH, Satani N, Martinez-Ledesma E, ... ... Sulman EP, et al. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell. 32: 42-56.e6. PMID 28697342 DOI: 10.1016/J.Ccell.2017.06.003  0.329
2017 Canella A, Welker AM, Yoo JY, Xu J, Abbas FS, Kesanakurti D, Nagarajan P, Beattie CE, Sulman EP, Liu JL, Gumin J, Lang FF, Gurcan M, Kaur B, Sampath D, et al. Efficacy of Onalespib a Long-acting Second Generation HSP90 Inhibitor as a Single Agent and in Combination with Temozolomide Against Malignant Gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28679777 DOI: 10.1158/1078-0432.Ccr-16-3151  0.376
2017 Wu J, Frady LN, Bash RE, Cohen SM, Schorzman AN, Su YT, Irvin DM, Zamboni WC, Wang X, Frye SV, Ewend MG, Sulman EP, Gilbert MR, Earp HS, Miller CR. MerTK as a therapeutic target in glioblastoma. Neuro-Oncology. PMID 28605477 DOI: 10.1093/Neuonc/Nox111  0.301
2017 Wang Y, Wu S, Zheng S, Wang S, Wali A, Ezhilarasan R, Sulman EP, Koul D, Yung WKA. APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death. Oncotarget. PMID 28493832 DOI: 10.18632/oncotarget.17348  0.332
2017 Shahar T, Rozovski U, Hess KR, Hossain A, Gumin J, Gao F, Fuller GN, Goodman L, Sulman EP, Lang FF. Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival. Neuro-Oncology. 19: 660-668. PMID 28453745 DOI: 10.1093/Neuonc/Now239  0.742
2017 Koul D, Wang S, Wu S, Saito N, Zheng S, Gao F, Kaul I, Setoguchi M, Nakayama K, Koyama K, Shiose Y, Sulman EP, Hirota Y, Yung WKA. Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma. Oncotarget. 8: 21741-21753. PMID 28423515 DOI: 10.18632/Oncotarget.15566  0.412
2017 Ballester LY, Fuller GN, Powell SZ, Sulman EP, Patel KP, Luthra R, Routbort MJ. Retrospective Analysis of Molecular and Immunohistochemical Characterization of 381 Primary Brain Tumors. Journal of Neuropathology and Experimental Neurology. 76: 179-188. PMID 28395087 DOI: 10.1093/Jnen/Nlw119  0.355
2017 Powell RT, Olar A, Narang S, Rao G, Sulman E, Fuller GN, Rao A. Identification of Histological Correlates of Overall Survival in Lower Grade Gliomas Using a Bag-of-words Paradigm: A Preliminary Analysis Based on Hematoxylin & Eosin Stained Slides from the Lower Grade Glioma Cohort of The Cancer Genome Atlas. Journal of Pathology Informatics. 8: 9. PMID 28382223 DOI: 10.4103/Jpi.Jpi_43_16  0.375
2017 McNeill RS, Canoutas DA, Stuhlmiller TJ, Dhruv HD, Irvin DM, Bash RE, Angus SP, Herring LE, Simon JM, Skinner KR, Limas JC, Chen X, Schmid RS, Siegel MB, Van Swearingen AE, ... ... Sulman EP, et al. Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma. Neuro-Oncology. PMID 28379424 DOI: 10.1093/Neuonc/Nox044  0.331
2017 Thomas JG, Parker Kerrigan BC, Hossain A, Gumin J, Shinojima N, Nwajei F, Ezhilarasan R, Love P, Sulman EP, Lang FF. Ionizing radiation augments glioma tropism of mesenchymal stem cells. Journal of Neurosurgery. 1-9. PMID 28362237 DOI: 10.3171/2016.9.Jns16278  0.394
2017 Olar A, Wani KM, Wilson CD, Zadeh G, DeMonte F, Jones DT, Pfister SM, Sulman EP, Aldape KD. Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma. Acta Neuropathologica. PMID 28130639 DOI: 10.1007/S00401-017-1678-X  0.377
2017 Boonyawan K, Yang J, Long L, Wang Q, Ezhilarasan R, Alessandra A, Hess KR, Alfaro K, Groot JFD, Bhat K, Sulman EP. Relative thrombocytosis following chemoradiation of patients with glioblastoma to predict survival. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E13527  0.387
2017 Hossain MB, Shifat R, Li J, Rivera-Mokina Y, Martinez FP, Johnson DG, Bedford MT, Hung M, Sulman EP, Lang F, Sawaya R, Fueyo J, Gomez-Manzano C. Abstract 5854: TIE2-mediated epigenetic marks regulate therapeutic resistance of glioblastoma Cancer Research. 77: 5854-5854. DOI: 10.1158/1538-7445.Am2017-5854  0.306
2017 Latha K, Yan J, Yang Y, Gressot LV, Kong L, Manyam G, Ezhilarasan R, Wang Q, Sulman EP, Xu J, Davis RE, Huang S, Fuller GN, Rao A, Heimberger AB, et al. Abstract 5606: Fibrinogen-like protein 2 drives malignant tumor progression in glioma Cancer Research. 77: 5606-5606. DOI: 10.1158/1538-7445.Am2017-5606  0.465
2017 Yang J, Wang Q, Long L, Ezhilarasan R, Sulman E. Abstract 3348: UniD: unified and integrated diagnostic pipeline for malignant gliomas based on DNA methylation data Cancer Research. 77: 3348-3348. DOI: 10.1158/1538-7445.Am2017-3348  0.415
2017 Zhang C, Juan M, Ding J, Gao F, Wu S, Li X, Sulman EP, Koul D, Yung WA. Abstract 2798: Identification of gamma secretase inhibitor (GSI)-responsive GBM patients: Involvement of NOTCH, p53, and PI3K/MAPK signaling Cancer Research. 77: 2798-2798. DOI: 10.1158/1538-7445.Am2017-2798  0.398
2017 Zinn PO, Luedi MM, Singh SK, Mosley J, Hassan I, Hatami M, Gumin J, Andereggen L, Sulman EP, Lang FF, Stueber F, Fuller GN, Colen RR. 222 Dexamethasone Induces Mesenchymal Trans-differentiation and Promotes Hallmarks of Cancer in Glioblastoma Neurosurgery. 64: 260-261. DOI: 10.1093/Neuros/Nyx417.222  0.307
2017 Yang J, Wang Q, Long L, Ezhilarasan R, Sulman E. GENE-36. ACCURATE DETECTION OF TERT PROMOTER MUTATION IN GLIOMAS USING INFINIUM DNA METHYLATION ARRAYS IDENTIFIES NOVEL EPIGENETIC ASSOCIATION Neuro-Oncology. 19: vi100-vi100. DOI: 10.1093/Neuonc/Nox168.409  0.303
2017 Danussi C, Bose P, Parthasarathy P, Silberman P, Arnam JSV, Vitucci M, Tang O, Heguy A, Chan T, Sulman E, Lang F, Creighton CJ, Deneen B, Miller CR, Picketts D, et al. Gene-24. Atrx Deficiency In Glioma Cells Of Origin Promotes Disease-Defining Phenotypes By Way Of Global Epigenomic Remodeling Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.398  0.331
2017 Zhang Z, Ezhilarasan R, Ding Y, Wang Q, Yang J, Long L, Verhaak R, Sulman E. DRES-04. DEVELOPMENT OF A CRISPR-CAS9D10A TARGETABLE, HIGH-COMPLEXITY, SINGLE-CELL BARCODING APPROACH FOR ISOLATION OF TREATMENT RESISTANT SUBCLONES FROM HETEROGENOUS MALIGNANT GLIOMAS Neuro-Oncology. 19: vi64-vi64. DOI: 10.1093/Neuonc/Nox168.262  0.329
2017 Wang Q, Ezhilarasan R, Goodman L, Eskilsson E, Yang J, Gumin J, Zheng S, Tang M, Jaffari M, Long L, Yoshihara K, Sun P, Heffernan T, Yung WKA, Draetta G, ... ... Sulman E, et al. TMOD-04. A COMPREHENSIVE GENOMIC LANDSCAPE OF GLIOMA SPHEROID CULTURES RECAPITULATES THE HETEROGENEITY OF GLIOBLASTOMA AND IDENTIFIES DNA METHYLATION PREDICTORS OF RADIOTHERAPY RESPONSE Neuro-Oncology. 19: vi255-vi255. DOI: 10.1093/Neuonc/Nox168.1043  0.698
2017 Wang Q, Hu B, Hu X, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel FP, Cho HJ, Lin Y, Satani N, Martinez-Ledesma E, Zheng S, ... ... Sulman E, et al. TMIC-22. DECIPHERING GLIOMA INTRINSIC TRANSCRIPTIONAL SUBTYPES IDENTIFIES TUMOR EVOLUTION ASSOCIATES WITH CHANGES IN IMMUNE-MICROENVIRONMENT Neuro-Oncology. 19: vi247-vi248. DOI: 10.1093/Neuonc/Nox168.1011  0.359
2017 McCarty J, Sulman E, Rao G, Wang Q, Lang F, Guerrero P. Angi-17. Glioblastoma Stem Cells Exploit The Alphavbeta8 Integrin-Tgfbeta Signaling Axis To Drive Tumor Initiation And Progression Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.095  0.399
2016 Reardon DA, Lassman AB, van den Bent M, Kumthekar P, Merrell R, Scott AM, Fichtel L, Sulman EP, Gomez E, Fischer J, Lee HJ, Munasinghe W, Xiong H, Mandich H, Roberts-Rapp L, et al. Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma. Neuro-Oncology. PMID 28039367 DOI: 10.1093/Neuonc/Now257  0.345
2016 Shahar T, Rozovski U, Hess KR, Hossain A, Gumin J, Gao F, Fuller GN, Goodman L, Sulman EP, Lang FF. Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival. Neuro-Oncology. PMID 27994067 DOI: 10.1093/neuonc/now239  0.318
2016 Sulman EP, Ismaila N, Armstrong TS, Tsien C, Batchelor TT, Cloughesy T, Galanis E, Gilbert M, Gondi V, Lovely M, Mehta M, Mumber MP, Sloan A, Chang SM. Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016707562. PMID 27893327 DOI: 10.1200/Jco.2016.70.7562  0.321
2016 Hu B, Wang Q, Wang YA, Hua S, Sauvé CG, Ong D, Lan ZD, Chang Q, Ho YW, Monasterio MM, Lu X, Zhong Y, Zhang J, Deng P, Tan Z, ... ... Sulman EP, et al. Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth. Cell. 167: 1281-1295.e18. PMID 27863244 DOI: 10.1016/J.Cell.2016.10.039  0.44
2016 Hossain MB, Shifat R, Johnson DG, Bedford MT, Gabrusiewicz KR, Cortes-Santiago N, Luo X, Lu Z, Ezhilarasan R, Sulman EP, Jiang H, Li SS, Lang FF, Tyler J, Hung MC, et al. TIE2-mediated tyrosine phosphorylation of H4 regulates DNA damage response by recruiting ABL1. Science Advances. 2: e1501290. PMID 27757426 DOI: 10.1126/Sciadv.1501290  0.303
2016 Luedi MM, Singh SK, Mosley JC, Hatami M, Gumin J, Sulman EP, Lang FF, Stueber F, Zinn PO, Colen RR. A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients. Journal of Neurosurgical Anesthesiology. PMID 27653222 DOI: 10.1097/Ana.0000000000000368  0.455
2016 Shingu T, Holmes L, Henry V, Wang Q, Latha K, Gururaj AE, Gibson LA, Doucette T, Lang FF, Rao G, Yuan L, Sulman EP, Farrell NP, Priebe W, Hess KR, et al. Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells. Journal of Translational Medicine. 14: 46. PMID 26861698 DOI: 10.1186/S12967-016-0803-2  0.387
2016 Kim SH, Ezhilarasan R, Phillips E, Gallego-Perez D, Sparks A, Taylor D, Ladner K, Furuta T, Sabit H, Chhipa R, Cho JH, Mohyeldin A, Beck S, Kurozumi K, Kuroiwa T, ... ... Sulman EP, et al. Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner. Cancer Cell. 29: 201-213. PMID 26859459 DOI: 10.1016/J.Ccell.2016.01.005  0.329
2016 Zinn P, Singh S, Luedi MM, Zandi F, Kotrotsou A, Hatami M, Thomas G, Elakkad A, Gumin J, Sulman EP, Lang F, Piwnica-Worms D, Colen RR. Abstract 4217: First pre-clinical validation of radiogenomics in glioblastoma Cancer Research. 76: 4217-4217. DOI: 10.1158/1538-7445.Am2016-4217  0.337
2016 Nguyen C, Piao Y, Martinez-Ledesma JE, Dong J, Park SY, Verhaak R, Sulman E, Groot JFD. Abstract 2815: Antitumor activity of CDK4/6 inhibition in combination with radiation therapy on glioblastoma stem cells Cancer Research. 76: 2815-2815. DOI: 10.1158/1538-7445.Am2016-2815  0.405
2016 Wang Q, Ezhilarasan R, Eskilsson E, Gumin J, Yang J, Jaffari M, Tang M, Aldape KD, Lang FF, Verhaak RGW, Sulman EP. Abstract 1646: A glioblastoma methylation assay (GaMA) developedfrom genomic analysis of glioma spheroid cultures predicts response toradiation therapy in patients with glioblastoma Cancer Research. 76: 1646-1646. DOI: 10.1158/1538-7445.Am2016-1646  0.405
2016 Zhang J, Wu C, Zhang J, Fujimoto J, Song X, Mao X, Sun H, Seth S, Thornton R, Coyle M, Little L, Gumbs C, Behrens C, Chow C, Sulman E, et al. Abstract 156: Integrated exome and transcriptome sequencing of primary lung cancers and paired distant metastases Cancer Research. 76: 156-156. DOI: 10.1158/1538-7445.Am2016-156  0.386
2016 Colen RR, Luedi M, Singh SK, Hassan I, Gumin J, Sulman EP, Lang FF, Zinn PO. Abstract 1505: Radiogenomics defines key genomic network driving GBM invasion Cancer Research. 76: 1505-1505. DOI: 10.1158/1538-7445.Am2016-1505  0.389
2016 Wang Q, Hu X, Muller F, Kim H, Squatrito M, Mikkelsen T, Scarpace L, Barthel F, Lin Y, Satani N, Martinez-Ledesma E, Chang E, Olar A, Hu B, deCarvalho A, ... ... Sulman E, et al. TMIC-14. TUMOR EVOLUTION OF GLIOMA INTRINSIC GENE EXPRESSION SUBTYPE ASSOCIATES WITH IMMUNOLOGICAL CHANGES IN THE MICROENVIRONMENT Neuro-Oncology. 18: vi202-vi202. DOI: 10.1093/Neuonc/Now212.854  0.395
2016 Audia A, Minata M, Guo X, Mukheef F, Patel H, Ezhilarasan R, Sulman E, Nakano I, Bhat K. Stmc-36. Cd109 Regulates Tumor Propagation Of Radio-Resistant Glioma Stem Cells Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.799  0.408
2016 Alvarez A, Huang T, Pangeni R, Lu S, Brennan C, Sulman E, Lu X, Nakano I, Zhang W, Zhang Z, Hu B, Cheng S. STMC-35. DIVERGENT Wnt SIGNALING REGULATES GLIOMA STEM CELLS AND TUMOR PHENOTYPE Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.798  0.406
2016 Olar A, Ezhilarasan R, Mehrotra M, Manekia J, Singh R, Sulman E, Luthra R. Mpth-46. A Pilot Study Identifying Circulating Cell-Free Tumor Dna Alterations In Patients With Glioblastoma Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.481  0.414
2016 Yang J, Wang Q, Long L, Ezhilarasan R, Olar A, Sulman E. Gent-39. A Unified Diagnostic Platform For Malignant Gliomas To Assess Radiation Response, Tcga Subclass, Copy Number Alteration (Cna), G-Cimp Status, And Mgmt Promoter Hypermethylation Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.345  0.328
2015 Gupta SK, Kizilbash SH, Carlson BL, Mladek AC, Boakye-Agyeman F, Bakken KK, Pokorny JL, Schroeder MA, Decker PA, Cen L, Eckel-Passow JE, Sarkar G, Ballman KV, Reid JM, Jenkins RB, ... ... Sulman EP, et al. Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma. Journal of the National Cancer Institute. 108. PMID 26615020 DOI: 10.1093/Jnci/Djv369  0.334
2015 Sathyan P, Zinn PO, Marisetty AL, Liu B, Kamal MM, Singh SK, Bady P, Lu L, Wani KM, Veo BL, Gumin J, Kassem DH, Robinson F, Weng C, Baladandayuthapani V, ... ... Sulman EP, et al. Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 15097-112. PMID 26558781 DOI: 10.1523/Jneurosci.1265-15.2015  0.361
2015 Reddy JP, Dawood S, Mitchell M, Debeb BG, Bloom E, Gonzalez-Angulo AM, Sulman EP, Buchholz TA, Woodward WA. Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 26482599 DOI: 10.1016/J.Radonc.2015.10.009  0.305
2015 Balasubramaniyan V, Vaillant B, Wang S, Gumin J, Butalid ME, Sai K, Mukheef F, Kim SH, Boddeke HW, Lang F, Aldape K, Sulman EP, Bhat KP, Colman H. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting. Oncotarget. 6: 31007-17. PMID 26307681 DOI: 10.18632/Oncotarget.5219  0.385
2015 Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, ... ... Sulman EP, et al. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. The New England Journal of Medicine. 372: 2481-98. PMID 26061751 DOI: 10.1056/Nejmoa1402121  0.312
2015 Olar A, Sulman EP. Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification. Seminars in Radiation Oncology. 25: 155-163. PMID 26050585 DOI: 10.1016/J.Semradonc.2015.02.006  0.397
2015 Hossain A, Gumin J, Gao F, Figueroa J, Shinojima N, Takezaki T, Priebe W, Villarreal D, Kang SG, Joyce C, Sulman E, Wang Q, Marini FC, Andreeff M, Colman H, et al. Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway. Stem Cells (Dayton, Ohio). 33: 2400-15. PMID 25966666 DOI: 10.1002/Stem.2053  0.353
2015 Kim SH, Joshi K, Ezhilarasan R, Myers TR, Siu J, Gu C, Nakano-Okuno M, Taylor D, Minata M, Sulman EP, Lee J, Bhat KP, Salcini AE, Nakano I. EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner. Stem Cell Reports. 4: 226-38. PMID 25601206 DOI: 10.1016/J.Stemcr.2014.12.006  0.45
2015 Lichti CF, Mostovenko E, Wadsworth PA, Lynch GC, Pettitt BM, Sulman EP, Wang Q, Lang FF, Rezeli M, Marko-Varga G, Végvári Á, Nilsson CL. Systematic identification of single amino acid variants in glioma stem-cell-derived chromosome 19 proteins. Journal of Proteome Research. 14: 778-86. PMID 25399873 DOI: 10.1021/Pr500810G  0.331
2015 Olar A, Wani KM, Sulman EP, Mansouri A, Zadeh G, Wilson CD, DeMonte F, Fuller GN, Aldape KD. Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma. Brain Pathology (Zurich, Switzerland). 25: 266-75. PMID 25040885 DOI: 10.1111/Bpa.12174  0.381
2015 Sarkaria JN, Gupta S, Kizilbash SH, Carlson B, Mladek A, Bakken K, Schroeder MA, Decker PA, Sulman EP, Eckel-Passow J, Kitange G, Jenkins RB. Delineation of MGMT promoter hypermethylation as a predictive biomarker for the A071102 clinical trial of veliparib combined with temozolomide (TMZ) using patient-derived xenograft (PDX) GBM models. Journal of Clinical Oncology. 33: 2052-2052. DOI: 10.1200/Jco.2015.33.15_Suppl.2052  0.317
2015 Dong J, Nguyen N, Ezhilarasan R, Wu S, Piao Y, Park SY, Tiao N, Stephan C, Sulman EP, Groot JFd. Abstract 695: Synergistic antitumor effects of polo like kinase inhibitor volasertib in combination with ionizing radiation in glioblastoma Cancer Research. 75: 695-695. DOI: 10.1158/1538-7445.Am2015-695  0.382
2015 Jiang W, Rodriguez Y, Boehling NS, Prabhu SS, Kim BYS, Hwu P, Sulman EP, Brown PD, Li J. Abstract 532: Circulating myeloid precursor profile as potential marker to differentiate radiation changes from tumor recurrence after brain stereotactic radiosurgery Cancer Research. 75: 532-532. DOI: 10.1158/1538-7445.Am2015-532  0.442
2015 Olar A, Wani K, Diefes K, Heathcock L, Thuijl Hv, Gilbert M, Armstrong T, Sulman E, Cahill D, Reijneveld J, Ylstra B, Wesseling P, Aldape K. Abstract 5270: IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas Cancer Research. 75: 5270-5270. DOI: 10.1158/1538-7445.Am2015-5270  0.378
2015 Wang Q, Ezhilarasan R, Goodman LD, Gumin J, Zheng S, Yoshihara K, Sun P, Yang J, Heffernan T, Draetta G, Aldape KD, Lang FF, Verhaak RGW, Sulman EP. Abstract 4795: A novel gene fusion in glioblastoma and a radiation response methylation signature identified by genomic characterization of glioma sphere-forming cells Cancer Research. 75: 4795-4795. DOI: 10.1158/1538-7445.Am2015-4795  0.775
2015 Shingu T, Holmes L, Henry V, Latha K, Gururaj AE, Gibson LA, Doucette T, Lang FF, Rao G, Yuan L, Sulman EP, Farrell NP, Priebe W, Hess KR, Wang YA, et al. Abstract 3483: Synergistic combination therapy with molecular targeted drugs in glioma stem-like cells Cancer Research. 75: 3483-3483. DOI: 10.1158/1538-7445.Am2015-3483  0.437
2015 Hossain MB, Shifat R, Johnson DG, Bedford MT, Hung M, Cortes-Santiago N, Gabrusiewicz K, Gumin J, Ezhilarasan R, Sulman EP, Lang F, Sawaya R, Yung WKA, Fueyo J, Gomez-Manzano C. Abstract 3298: ABL1 is required for Tie2-mediated DNA repair in brain tumor stem cells Cancer Research. 75: 3298-3298. DOI: 10.1158/1538-7445.Am2015-3298  0.443
2015 Moreno M, Pineda E, Martínez J, Bejarano L, Balasubramaniyan V, Ezhilarasan R, Kallarackal N, Kim S, Paré L, Tortosa A, Gómez-Manzano C, Graus F, Sulman E, Piao X, Nakano I, et al. Stem-08Inhibition Of The Neural Stem Cell/Oligodendrocyte Progenitor Factor Gpr56 Promotes The Proneural To Mesenchymal Transition And Radioresistance In Glioblastoma Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov234.08  0.411
2015 Hossain MB, Shifat R, Johnson DG, Bedford MT, Hung M, Gabrusiewicz K, Gumin J, Ezhilarasan R, Sulman EP, Lang F, Tyler J, Sawaya R, Yung WA, Fueyo J, Gomez-Manzano C. RTRB-10TYROSINE KINASE RECEPTOR TIE2 REGULATES DNA REPAIR THROUGH THE PROTO-ONCOGENE ABL1 IN BRAIN TUMOR STEM CELLS Neuro-Oncology. 17: v197.2-v197. DOI: 10.1093/Neuonc/Nov231.10  0.448
2015 Wefel J, Sulman E, Zhou R, Liu Y, Scheurer M, Bondy M. NCO-16GENETIC MODULATION OF NEUROCOGNITIVE DECLINE IN GLIOMA PATIENTS Neuro-Oncology. 17: v149.3-v149. DOI: 10.1093/Neuonc/Nov223.16  0.329
2015 Olar A, Goodman L, Wani K, Boehling N, DeMonte F, Aldape K, Sulman E. Mpth-25An 18-Gene Expression Signature Predicts Recurrence-Free Survival In Meningioma Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov222.25  0.42
2015 Wang Q, Hu X, Muller F, Kim H, Mikkelsen T, Scarpace L, Lin Y, Satani N, Chang E, Olar A, Decarvalho A, Eskilsson E, Rabadan R, Iavarone A, Finocchiaro G, ... ... Sulman E, et al. MTR-19A MACROPHAGE-/MICROGLIAL-RICH TUMOR MICROENVIRONMENT MIMICS PRONEURAL TO MESENCHYMAL TRANSITION IN GLIOBLASTOMA Neuro-Oncology. 17: v128.3-v128. DOI: 10.1093/Neuonc/Nov219.19  0.459
2015 Wang Q, Eskilsson E, Ezhilarasan R, Zheng S, Gumin J, Heffernan T, Draetta G, Lang F, Verhaak R, Sulman E. Geno-36Glioma Sphere-Forming Cells Reveal Intrinsic Global Hypermethylation Associated With Gbm Radiation Resistance Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov215.36  0.37
2015 Yang J, Wang Q, Ezhilarasan R, Jaffari M, Olar A, Verhaak R, Sulman E. Epig-19A Methylation Classification Of Glioblastoma That Accurately Predicts Gene Expression Subtype. Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov214.19  0.354
2015 Eskilsson E, Wang Q, Ezhilarasan R, Bhat KP, Tang M, Goodman LD, Aldape KD, Verhaak RG, Sulman EP. Epig-05Radioresistance Of Podoplanin-Expressing Glioma Stem Cells Is Associated With Ezh2-Driven Polycomb Repressive Complex Activity Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov214.05  0.754
2015 Hashimoto Y, Yaghi NK, Wei J, Huang N, Ezhilarasan R, Kong L, Zhou S, Chivukula P, Webb DC, Priebe W, Payne JE, Sulman EP, Heimberger AB. BMET-14STAT3 INHIBITION ENHANCES THERAPEUTIC EFFICACY OF RADIATION TREATMENT AGAINST ESTABLISHED BRAIN METASTASIS IN MURINE MELANOMA MODEL Neuro-Oncology. 17: v47.5-v48. DOI: 10.1093/Neuonc/Nov208.14  0.356
2015 Koul D, Wang S, Saito N, Zheng S, Wu S, Setoguchi M, Nakayama K, Koyama K, Shiose Y, Sulman EP, Hirota Y, Yung WKA. Atps-46Preclinical Therapeutic Efficacy Of A Novel Blood-Brain Barrier-Penetrant Dual Pi3K/Mtor Inhibitor With Preferential Response In Pi3K/Pten Mutant Glioma Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov204.46  0.412
2015 Dong J, Ezhilarasan R, Wu S, Sulman E, de Groot J. ATPS-20AURORA KINASE B INHIBITOR AT9283 ENHANCED RADIATION THERAPY IN GLIOBLASTOMA Neuro-Oncology. 17: v22.3-v22. DOI: 10.1093/Neuonc/Nov204.20  0.42
2015 Dong J, Nguyen N, Ezhilarasan R, Wu S, Henry V, Piao Y, Park SY, Tiao N, Stephan C, Sulman E, de Groot J. ATPS-19POLO LIKE KINASE INHIBITOR VOLASERTIB SYNERGISTICALLY IMPROVE RADIATION EFFICACY IN GLIOBLASTOMA Neuro-Oncology. 17: v22.2-v22. DOI: 10.1093/Neuonc/Nov204.19  0.402
2015 Lichti CF, Wildburger NC, Shavkunov AS, Mostovenko E, Liu H, Sulman EP, Nilsson CL. The proteomic landscape of glioma stem-like cells Eupa Open Proteomics. 8: 85-93. DOI: 10.1016/J.Euprot.2015.06.008  0.406
2014 Koul D, Yao J, Wan S, Yuan Y, Sulman E, Lang F, Yung WK, Colman H. Retraction: Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig 2-positive glioma tumor-initiating cells. Cancer Research. 74: 6731-2. PMID 25398854 DOI: 10.1158/0008-5472.Can-14-2966  0.378
2014 Verma J, Sulman EP, Jhingran A, Tucker SL, Rauch GM, Eifel PJ, Klopp AH. Dosimetric predictors of duodenal toxicity after intensity modulated radiation therapy for treatment of the para-aortic nodes in gynecologic cancer. International Journal of Radiation Oncology, Biology, Physics. 88: 357-62. PMID 24411609 DOI: 10.1016/J.Ijrobp.2013.09.053  0.323
2014 Lichti CF, Liu H, Shavkunov AS, Mostovenko E, Sulman EP, Ezhilarasan R, Wang Q, Kroes RA, Moskal JC, Fenyö D, Oksuz BA, Conrad CA, Lang FF, Berven FS, Végvári A, et al. Integrated chromosome 19 transcriptomic and proteomic data sets derived from glioma cancer stem-cell lines. Journal of Proteome Research. 13: 191-9. PMID 24266786 DOI: 10.1021/Pr400786S  0.386
2014 Saito N, Fu J, Zheng S, Yao J, Wang S, Liu DD, Yuan Y, Sulman EP, Lang FF, Colman H, Verhaak RG, Yung WK, Koul D. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells. Stem Cells (Dayton, Ohio). 32: 301-12. PMID 24038660 DOI: 10.1002/Stem.1528  0.426
2014 Niola F, Zhao X, Singh D, Sullivan R, Castano A, Verrico A, Zoppoli P, Friedmann-Morvinski D, Sulman EP, Barrett L, Zhuang Y, Verma I, Benezra R, Aldape K, Iavarone A, et al. Erratum: Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis (The Journal of Clinical Investigation (2013) 123:1 (405-417) (DOI: 10.1172/JCI63811) Journal of Clinical Investigation. 124. DOI: 10.1172/Jci77927  0.303
2014 Hossain MB, Cortes-Santiago N, Fan X, Gabrusiewicz K, Gumin J, Sulman EP, Lang F, Sawaya R, Yung WKA, Fueyo J, Gomez-Manzano C. Abstract 3944: Caveolin-mediated Tie2 nuclear translocation results in enhanced NHEJ repair and glioma radioresistance Cancer Research. 74: 3944-3944. DOI: 10.1158/1538-7445.Am2014-3944  0.424
2014 Thomas C, Liang J, Piao Y, Nguyen N, Sulman E, Stephan C, Yung A, Groot JFd. Abstract 3744: High-throughput in vitro screening of glioma stem cell lines: Evaluation of over 350 tyrosine kinase inhibitors Cancer Research. 74: 3744-3744. DOI: 10.1158/1538-7445.Am2014-3744  0.353
2014 Nilsson CL, Vegvari A, Mostovenko E, Lichti CF, Fenyo D, Ruggles K, Sulman EP. SC-23 * THE ROLE OF SINGLE AMINO ACID POLYMORPHISMS IN GLIOMA STEM CELL PHENOTYPES Neuro-Oncology. 16: v202-v202. DOI: 10.1093/Neuonc/Nou275.23  0.434
2014 Singh S, Burrell K, Alamhabspour A, Agnihotri S, Vartanian A, Jalali S, Gumin J, Sulman E, Lang F, Zadeh G. Mr-04Dicer Regulates Glioma Stem Cell State Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou262.4  0.433
2014 Wang Q, Ezhilarasan R, Zheng S, Gumin J, Heffernan T, Draetta G, Lang F, Verhaak R, Sulman E. Ge-39Validation Of Glioma Sphere-Forming Cells As Models Of Glioblastoma And Identification Of Novel Drivers Of Tumorigenesis Through Comprehensive Genomic Characterization Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou256.38  0.461
2014 Wang Q, Ezhilarasan R, Zheng S, Gumin J, Heffernan T, Draetta G, Lang F, Verhaak R, Sulman E. Ge-38Identifying The Treatment-Resistant Mesenchymal Signature By Comparative Analyses Between Glioma Sphere-Forming Cells And Their Glioblastomas Of Origin Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou256.37  0.454
2014 Olar A, Wani K, Mansouri A, Zadeh G, Wilson C, DeMonte F, Fuller G, Jones D, Pfister S, Deimling Av, Sulman E, Aldape K. EG-09EPIGENETIC PROFILING REVEALS A CpG HYPERMETHYLATION PHENOTYPE (CIMP) ASSOCIATED WITH WORSE PROGRESSION-FREE SURVIVAL IN MENINGIOMA. Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou254.9  0.344
2014 Sulman EP, Wang Q, Ezhilarasan R, Goodman LD, Gumen J, Sun P, Aldape K, Yung WA, Heffernan T, Draetta GF, Lang FF. The Treatment-Resistant Mesenchymal Signature In Glioblastoma Derives From Tumor Cells Independent Of Stroma Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou206.28  0.754
2014 Aldape K, Zadeh G, Sulman E. Molecular-Based Grading In Idh-Mutant Lower Grade Gliomas Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou206.17  0.373
2013 Bhat KP, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, Wani K, Heathcock L, James JD, Goodman LD, Conroy S, Long L, Lelic N, Wang S, Gumin J, ... ... Sulman EP, et al. Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. Cancer Cell. 24: 331-46. PMID 23993863 DOI: 10.1016/J.Ccr.2013.08.001  0.727
2013 Piao Y, Liang J, Holmes L, Henry V, Sulman E, de Groot JF. Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4392-403. PMID 23804423 DOI: 10.1158/1078-0432.Ccr-12-1557  0.419
2013 Zheng S, Fu J, Vegesna R, Mao Y, Heathcock LE, Torres-Garcia W, Ezhilarasan R, Wang S, McKenna A, Chin L, Brennan CW, Yung WK, Weinstein JN, Aldape KD, Sulman EP, et al. A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival. Genes & Development. 27: 1462-72. PMID 23796897 DOI: 10.1101/Gad.213686.113  0.389
2013 Tsai CJ, Sulman EP, Eifel PJ, Jhingran A, Allen PK, Deavers MT, Klopp AH. Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix. Gynecologic Oncology. 131: 645-9. PMID 23643871 DOI: 10.1016/J.Ygyno.2013.04.056  0.422
2013 Fu J, Koul D, Yao J, Wang S, Yuan Y, Colman H, Sulman EP, Lang FF, Yung WK. Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cells. Cancer Research. 73: 3062-74. PMID 23492364 DOI: 10.1158/0008-5472.Can-12-2033  0.388
2013 Niola F, Zhao X, Singh D, Sullivan R, Castano A, Verrico A, Zoppoli P, Friedmann-Morvinski D, Sulman E, Barrett L, Zhuang Y, Verma I, Benezra R, Aldape K, Iavarone A, et al. Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis. The Journal of Clinical Investigation. 123: 405-17. PMID 23241957 DOI: 10.1172/Jci63811  0.473
2013 Holliday EB, Sulman EP. Tumor prognostic factors and the challenge of developing predictive factors. Current Oncology Reports. 15: 33-46. PMID 23224629 DOI: 10.1007/S11912-012-0283-3  0.417
2013 Likhacheva A, Pinnix CC, Parikh NR, Allen PK, McAleer MF, Chiu MS, Sulman EP, Mahajan A, Guha-Thakurta N, Prabhu SS, Cahill DP, Luo D, Shiu AS, Brown PD, Chang EL. Predictors of survival in contemporary practice after initial radiosurgery for brain metastases. International Journal of Radiation Oncology, Biology, Physics. 85: 656-61. PMID 22898384 DOI: 10.1016/J.Ijrobp.2012.05.047  0.357
2013 Sulman EP, Won M, Blumenthal DT, Vogelbaum MA, Colman H, Jenkins RB, Chakravarti A, Jeraj R, Brown PD, Jaeckle KA, Schiff D, Dignam J, Atkins JN, Brachman D, Werner-Wasik M, et al. Molecular predictors of outcome and response to bevacizumab (BEV) based on analysis of RTOG 0825, a phase III trial comparing chemoradiation (CRT) with and without BEV in patients with newly diagnosed glioblastoma (GBM). Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.Lba2010  0.371
2013 Gilbert MR, Dignam J, Won M, Blumenthal DT, Vogelbaum MA, Aldape KD, Colman H, Chakravarti A, Jeraj R, Armstrong TS, Wefel JS, Brown PD, Jaeckle KA, Schiff D, Atkins JN, ... ... Sulman EP, et al. RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM). Journal of Clinical Oncology. 31: 1-1. DOI: 10.1200/Jco.2013.31.15_Suppl.1  0.337
2013 Fu J, Koul D, Zheng S, Singh V, Yao J, Zheng Y, Lu Z, Sulman EP, Lang FF, Yung AWK. Abstract 4909: Olig2 phosphorylation by CDK2 implicated in glioma proliferation. Cancer Research. 73: 4909-4909. DOI: 10.1158/1538-7445.Am2013-4909  0.377
2013 Saito N, Fu J, Wang S, Sulman EP, Lang FF, Yung WA, Koul D. Abstract 235: Oncogene addiction switch from NOTCH to PI3K/AKT requires simultaneous targeting of NOTCH and PI3K pathway inhibition in glioblastoma. Cancer Research. 73: 235-235. DOI: 10.1158/1538-7445.Am2013-235  0.373
2013 Cahill DP, George A, Gilbert MR, Chakravarti A, Stupp R, Hegi M, Brown P, Jaeckle KA, Corn B, Sulman EP, Souhami L, Werner-Wasik M, Anderson BM, Mehta M, Aldape KD. Abstract A110: EGFRvIII expression is associated with shorter progression-free and overall survival in glioblastoma patients treated with standard-of-care temozolomide and radiation: A report from the RTOG-0525 trial. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-A110  0.409
2013 Sulman E, Ezhilarasan R, Goodman L, Wani K, Sharma D, Mody R, Cloughesy T, Lai A, DeMonte F, Aldape K. A Molecular Signature to Predict Meningioma Recurrence and Progression International Journal of Radiation Oncology*Biology*Physics. 87: S666. DOI: 10.1016/J.Ijrobp.2013.06.1765  0.666
2012 Likhacheva A, Pinnix CC, Parikh N, Allen PK, Guha-Thakurta N, McAleer M, Sulman EP, Mahajan A, Shiu A, Luo D, Chiu M, Brown PD, Prabhu SS, Chang EL. Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone. Journal of Neurosurgery. 117: 38-44. PMID 23205787 DOI: 10.3171/2012.3.Gks1289  0.376
2012 Debeb BG, Lacerda L, Xu W, Larson R, Solley T, Atkinson R, Sulman EP, Ueno NT, Krishnamurthy S, Reuben JM, Buchholz TA, Woodward WA. Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signaling. Stem Cells (Dayton, Ohio). 30: 2366-77. PMID 22961641 DOI: 10.1002/Stem.1219  0.375
2012 Li J, Sulman E, Aldape K. Molecular biology of brain tumors. Handbook of Clinical Neurology. 104: 23-34. PMID 22230432 DOI: 10.1016/B978-0-444-52138-5.00002-5  0.39
2012 Pinnix CC, Fontanilla HP, Hayes-Jordan A, Subbiah V, Bilton SD, Chang EL, Grosshans DR, McAleer MF, Sulman EP, Woo SY, Anderson P, Green HL, Mahajan A. Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery. International Journal of Radiation Oncology, Biology, Physics. 83: 317-26. PMID 22104361 DOI: 10.1016/J.Ijrobp.2011.06.1985  0.382
2012 Koay EJ, Bucheit AD, Jakob JA, Hyun ED, Settle SH, Brown PD, Davies MA, Sulman EP. Correlation of BRAF and NRAS mutation status with tumor characteristics and treatment outcomes in melanoma patients with brain metastasis. Journal of Clinical Oncology. 30: 8584-8584. DOI: 10.1200/Jco.2012.30.15_Suppl.8584  0.319
2012 Vaillant BD, Bhat K, Sulman EP, Balasubramaniyan V, Ezhilarasan R, Aldape KD, Colman H. The NF kappa B pathway as a key mediator of the glioblastoma mesenchymal subtype in glioblastoma stem cells and human tumors. Journal of Clinical Oncology. 30: 2002-2002. DOI: 10.1200/Jco.2012.30.15_Suppl.2002  0.464
2012 Chakravarti A, Wang M, Aldape KD, Sulman EP, Bredel M, Magliocco AM, Klimowicz AC, Hegi M, Stupp R, Gilbert MR, Curran WJ, Werner-Wasik M, Mahajan A, Schultz CJ, Mehta MP. A revised RTOG recursive partitioning analysis (RPA) model for glioblastoma based upon multiplatform biomarker profiles. Journal of Clinical Oncology. 30: 2001-2001. DOI: 10.1200/Jco.2012.30.15_Suppl.2001  0.354
2012 Bhat KPL, Vaillant B, Balasubramainyan V, Ezhilarasan R, Hollingsworth F, James J, Wani K, Goodman L, Sulman E, Colman H, Aldape K. Abstract 3314: Phenotypic plasticity in glioma stem cells mediated by NFκB signaling Cancer Research. 72: 3314-3314. DOI: 10.1158/1538-7445.Am2012-3314  0.734
2012 Kozono D, Nitta M, Sampetrean O, Kimberly N, Kushwaha D, Merzon D, Ligon K, Zhu S, Zhu K, Kim TH, Kwon C, Becher O, Saya H, Chen CC, Donovan LK, ... ... Sulman EP, et al. LAB-STEM CELLS Neuro-Oncology. 14: vi142-vi152. DOI: 10.1093/Neuonc/Nos239  0.307
2012 Proescholdt MA, Merrill MJ, Stoerr E, Lohmeier A, Brawanski A, Sim H, Hu B, Pineda CA, Yoon S, Viapiano MS, Rajappa P, Cobb WS, Huang Y, Lyden DC, Bromberg J, ... ... Sulman E, et al. LAB-ANGIOGENESIS AND INVASION Neuro-Oncology. 14: vi1-vi6. DOI: 10.1093/Neuonc/Nos219  0.32
2012 Sulman EP, Wang M, Cahill DP, Won M, Hegi M, Mehta M, Gilbert MR, Aldape KD. 287 Combining Molecular And Clinical Factors To Predict Survival Of Patients With Glioblastoma And Validation Using Rtog 0525 Radiotherapy and Oncology. 102. DOI: 10.1016/S0167-8140(12)70250-5  0.314
2011 Vaillant BD, Bhat K, Sulman EP, Balasubramaniyan V, Wang S, Aldape KD, Colman H. CD44 as a prognostic and predictive marker for GBM. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2049. PMID 28023811 DOI: 10.1200/Jco.2011.29.15_Suppl.2049  0.441
2011 Aldape KD, Wang M, Sulman EP, Hegi M, Colman H, Jones G, Chakravarti A, Mehta MP, Andrews DW, Long L, Diefes K, Heathcock L, Jenkins R, Schultz CJ, Gilbert MR, et al. RTOG 0525: Molecular correlates from a randomized phase III trial of newly diagnosed glioblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: LBA2000. PMID 27937153 DOI: 10.1200/Jco.2011.29.18_Suppl.Lba2000  0.319
2011 Bhat KP, Salazar KL, Balasubramaniyan V, Wani K, Heathcock L, Hollingsworth F, James JD, Gumin J, Diefes KL, Kim SH, Turski A, Azodi Y, Yang Y, Doucette T, Colman H, ... Sulman EP, et al. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes & Development. 25: 2594-609. PMID 22190458 DOI: 10.1101/Gad.176800.111  0.361
2011 Miller CA, Settle SH, Sulman EP, Aldape KD, Milosavljevic A. Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors. Bmc Medical Genomics. 4: 34. PMID 21489305 DOI: 10.1186/1755-8794-4-34  0.357
2011 de Groot JF, Sulman EP, Aldape KD. Multigene sets for clinical application in glioma. Journal of the National Comprehensive Cancer Network : Jnccn. 9: 449-56; quiz 457. PMID 21464148 DOI: 10.6004/Jnccn.2011.0040  0.423
2011 Bonato V, Baladandayuthapani V, Broom BM, Sulman EP, Aldape KD, Do KA. Bayesian ensemble methods for survival prediction in gene expression data. Bioinformatics (Oxford, England). 27: 359-67. PMID 21148161 DOI: 10.1093/Bioinformatics/Btq660  0.301
2011 Sulman EP, Aldape K. The use of global profiling in biomarker development for gliomas. Brain Pathology (Zurich, Switzerland). 21: 88-95. PMID 21129062 DOI: 10.1111/J.1750-3639.2010.00456.X  0.438
2011 Settle SH, Sulman EP. Tumor profiling: development of prognostic and predictive factors to guide brain tumor treatment. Current Oncology Reports. 13: 26-36. PMID 21082294 DOI: 10.1007/S11912-010-0138-8  0.421
2011 Goodman LD, Bhat K, Gumin J, Ezhilarasan R, Gao F, Love P, Colman H, Lang F, Aldape K, Sulman E. Abstract 3313: A proliferating population of glioma stem-like cells as characterized by expression of the cell surface glycoprotein CD58 Cancer Research. 71: 3313-3313. DOI: 10.1158/1538-7445.Am2011-3313  0.73
2011 Ezhilarasan R, Love PN, Goodman LD, Aldape KD, Sulman EP. Abstract 2467: Podoplanin expressing cancer stem cells show increased resistance to DNA damage induced by ionizing radiation Cancer Research. 71: 2467-2467. DOI: 10.1158/1538-7445.Am2011-2467  0.768
2010 Sulman EP, Guerrero M, Mikkelsen T, Bonato V, Phillips HS, Berger MS, Collins P, Broom B, Do K, Aldape KD. A mesenchymal/stem cell predictor of survival of patients with malignant gliomas. Journal of Clinical Oncology. 28: 2049-2049. DOI: 10.1200/Jco.2010.28.15_Suppl.2049  0.428
2010 Ezhilarasan R, Goodman LD, Love PN, Aldape KD, Sulman EP. Abstract 5157: Functional and regulatory role of src kinase in podoplanin expressing glioma cancer stem cells Cancer Research. 70: 5157-5157. DOI: 10.1158/1538-7445.Am10-5157  0.772
2010 Love PN, Ezhilarasan R, Goodman LD, Aldape KD, Sulman EP. Abstract 5147: Trancriptional activation of the glioma stem cell marker podoplanin by the homeobox transcription factor prox1 Cancer Research. 70: 5147-5147. DOI: 10.1158/1538-7445.Am10-5147  0.76
2010 Goodman LD, Gao F, Gumin J, Villareal D, Ezhilarasan R, Love P, Colman H, Lang FF, Aldape KD, Sulman EP. Abstract 4305: Refinement of the glioma cancer stem cell marker profile Cancer Research. 70: 4305-4305. DOI: 10.1158/1538-7445.Am10-4305  0.747
2010 Hyun ED, Cahill DP, McAleer MF, George A, Shiu AS, Mahajan A, Chang EL, Sulman EP. Outcome of Patients Treated with Gamma Knife Stereotactic Radiosurgery for Brain Metastases from Melanoma and Association of BRAF Oncogene Mutation Status with Survival International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.646  0.313
2010 Mahajan A, Anderson P, McAleer M, Sulman E, Pinnix C, Woo S, Herzog C, Hayes-Jordan A. Multidisciplinary Management with Whole Abdominal IMRT of Desmoplastic Small Round Cell Tumor International Journal of Radiation Oncology*Biology*Physics. 78: S593. DOI: 10.1016/J.Ijrobp.2010.07.1382  0.35
2009 Sulman EP, Guerrero M, Aldape K. Beyond grade: molecular pathology of malignant gliomas. Seminars in Radiation Oncology. 19: 142-9. PMID 19464628 DOI: 10.1016/J.Semradonc.2009.02.001  0.453
2009 Sulman EP, Komaki R, Klopp AH, Cox JD, Chang JY. Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer. Radiation Oncology (London, England). 4: 5. PMID 19183471 DOI: 10.1186/1748-717X-4-5  0.313
2009 Sulman EP, Eifel PJ, Jhingran A, Aldape KD, Deavers MT, Klopp AH. Podoplanin Expression is Prognostic for Survival of Patients with Squamous Cell Carcinoma of the Cervix Treated with Definitive Radiation Therapy International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.850  0.348
2009 Ezhilarasan R, Love PN, Goodman LD, Aldape KD, Sulman EP. Expression of c-met in Human Glioblastoma Does Not Correlate with Patient Survival or Clinical Radiation Response International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.581  0.707
2008 Sulman EP, Aldape K, Colman H. Brain tumor stem cells. Current Problems in Cancer. 32: 124-142. PMID 18501775 DOI: 10.1016/J.Currproblcancer.2008.02.004  0.392
2008 Rivera AL, Pelloski CE, Sulman E, Aldape K. Prognostic and predictive markers in glioma and other neuroepithelial tumors. Current Problems in Cancer. 32: 97-123. PMID 18501774 DOI: 10.1016/J.Currproblcancer.2008.02.003  0.391
2008 Woodward WA, Sulman EP. Cancer stem cells: markers or biomarkers? Cancer Metastasis Reviews. 27: 459-70. PMID 18437295 DOI: 10.1007/S10555-008-9130-2  0.335
2008 Lang FF, Gumin J, Amano T, Hata N, Heimberger AB, Marini F, Andreeff M, Aldape KD, Sulman E, Colman H. Tumor-derived mesenchymal stem cells in human gliomas: Isolation and biological properties Journal of Clinical Oncology. 26: 2001-2001. DOI: 10.1200/Jco.2008.26.15_Suppl.2001  0.419
2008 Sulman EP, Pelloski CE, Aldape KD. Analysis of Patients Receiving Histone Deacetylase Inhibiting Antiepileptic Agents during Radiation Treatment for Glioblastoma International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.696  0.331
Low-probability matches (unlikely to be authored by this person)
2019 Ott M, Hashimoto Y, Marisetty A, Wei J, Zamler D, Leu J, Kong L, Zhou S, Fuller G, de Groot J, Priebe W, Sulman E, Heimberger A. MLTI-01. IMMUNOLOGICAL REPROGRAMMING IN THE CNS TUMOR MICROENVIRONMENT AND THERAPEUTIC EFFICACY OF RADIOTHERAPY WITH STAT3 BLOCKADE Neuro-Oncology Advances. 1: i14-i14. DOI: 10.1093/noajnl/vdz014.060  0.3
2009 Beadle BM, Mahajan A, Chang EL, Woo SY, McAleer MF, Sulman EP, Suki D, Gilbert MR, Pelloski CE. Prognostic Factors and Outcomes of Patients Treated with Re-irradiation for Recurrent Glioblastoma International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.566  0.299
2017 Lee W, Gomez DR, Zhang J, Jalali A, Roh W, Reuben A, Lu W, Chow C, Wu CC, Fujimoto J, Antonoff M, Moran C, Sulman EP, Rao G, Swisher S, et al. Comprehensive molecular and immune profiling of non-small cell lung cancer and matched distant metastases to suggest distinct molecular mechanisms underlying metastasis. Journal of Clinical Oncology. 35: 8541-8541. DOI: 10.1200/Jco.2017.35.15_Suppl.8541  0.299
2000 Maris JM, Weiss MJ, Guo C, Gerbing RB, Stram DO, White PS, Hogarty MD, Sulman EP, Thompson PM, Lukens JN, Matthay KK, Seeger RC, Brodeur GM. Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 1888-99. PMID 10784629 DOI: 10.1200/Jco.2000.18.9.1888  0.298
2019 Farooqi A, Dharmiah S, Alvarez C, Yang J, Sharin V, Danussi C, Irwin D, Ezhilarasan R, Sulman EP, Huse J. ATRX Mutant Glioblastoma Stem Cell (GSC) Lines with the Alternative Lengthening of Telomeres Phenotype Display Sensitivity to G-Quadruplex Stabilization International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.2286  0.298
2013 Ghia AJ, Sulman EP. Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases: Sperduto PW, Kased N, Roberge D, et al (Univ of Minnesota Gamma Knife, Minneapolis; Univ of California-San Francisco; McGill Univ Health Ctr, Montreal, Quebec, Canada; Et al) Int J Radiat Oncol Biol Phys 82:2111-2117, 2012 Breast Diseases. 24: 175-176. DOI: 10.1016/J.Breastdis.2013.04.020  0.298
2007 Klopp AH, Chang JY, Tucker SL, Sulman EP, Balter PA, Liu HH, Bucci MK, Macapinlac HA, Komaki R, Cox JD. Intrathoracic patterns of failure for non-small-cell lung cancer with positron-emission tomography/computed tomography-defined target delineation. International Journal of Radiation Oncology, Biology, Physics. 69: 1409-16. PMID 17904303 DOI: 10.1016/J.Ijrobp.2007.05.085  0.298
2013 Penas-Prado M, Groves MD, Mammoser AG, Melguizo I, De Groot JF, Conrad CA, Tremont-Lukats I, Loghin ME, Puduvalli VK, Sulman EP, Hess KR, Aldape KD, Gilbert MR, Yung WKA. Phase I lead-in to a 2x2x2 factorial trial of dose-dense temozolomide, memantine, mefloquine, and metformin as postradiation adjuvant therapy of glioblastoma (GBM). Journal of Clinical Oncology. 31: TPS2106-TPS2106. DOI: 10.1200/Jco.2013.31.15_Suppl.Tps2106  0.297
2019 Kurz S, Silverman JS, Hochman T, Nayak L, Arrillaga-Romany I, Lee E, Patel A, Delara M, Hsu F, Imtiaz T, Magnelli L, Taylor J, Cloughesy T, Sulman E, Golfinos J, et al. ATIM-37. PHASE II, OPEN-LABEL, SINGLE ARM, MULTICENTER STUDY OF AVELUMAB WITH HYPOFRACTIONATED RADIATION (HFRT) FOR ADULT PATIENTS WITH SECONDARILY TRANSFORMED IDH-MUTANT GLIOBLASTOMA (GBM) Neuro-Oncology. 21: vi9-vi10. DOI: 10.1093/Neuonc/Noz175.036  0.297
2015 Subbiah IM, Lei X, Weinberg JS, Sulman EP, Chavez-MacGregor M, Tripathy D, Gupta R, Varma A, Chouhan J, Guevarra RP, Valero V, Gilbert MR, Gonzalez-Angulo AM. Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 2239-45. PMID 25987700 DOI: 10.1200/Jco.2014.58.8517  0.296
2010 Rivera AL, Pelloski CE, Gilbert MR, Colman H, De La Cruz C, Sulman EP, Bekele BN, Aldape KD. MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma. Neuro-Oncology. 12: 116-21. PMID 20150378 DOI: 10.1093/Neuonc/Nop020  0.296
2015 Li X, Liu Y, Granberg KJ, Wang Q, Moore LM, Ji P, Gumin J, Sulman EP, Calin GA, Haapasalo H, Nykter M, Shmulevich I, Fuller GN, Lang FF, Zhang W. Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene. 34: 1619-28. PMID 24747968 DOI: 10.1038/Onc.2014.98  0.295
2018 Wang Y, Yang J, Wu W, Shah R, Danussi C, Riggins G, Kannan K, Sulman E, Chan T, Huse J. Cadd-27. G-Quadruplex Dna Drives Genomic Instability And Represents A Targetable Molecular Abnormality In Atrx-Deficient Malignant Glioma Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.1168  0.294
1997 Maris JM, Guo C, Kyemba S, White PS, Sulman EP, Rajalingam V, Jensen SJ, Brodeur GM. #501 Localization of a neuroblastoma (NB) tumor suppressor gene (TSG) locus within chromosome bands 11q13-23 Journal of Pediatric Hematology Oncology. 19: 361. DOI: 10.1097/00043426-199707000-00035  0.294
2009 Klopp AH, Jhingran A, Eifel PJ, Deavers MT, Sulman EP. Galectin-7 is a Prognostic Factor for Radiation Response in Squamous Cell Carcinoma of the Cervix International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.835  0.293
2020 Cui X, Ma C, Vasudevaraja V, Serrano J, Tong J, Peng Y, Delorenzo M, Shen G, Frenster J, Morales RT, Qian W, Tsirigos A, Chi AS, Jain R, Kurz SC, ... Sulman EP, et al. Author response: Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy Elife. DOI: 10.7554/Elife.52253.Sa2  0.293
2015 Liu Y, Zhou R, Sulman EP, Scheurer ME, Boehling N, Armstrong GN, Tsavachidis S, Liang FW, Etzel CJ, Conrad CA, Gilbert MR, Armstrong TS, Bondy ML, Wefel JS. Genetic Modulation of Neurocognitive Function in Glioma Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 3340-6. PMID 25904748 DOI: 10.1158/1078-0432.Ccr-15-0168  0.292
2023 Stitzlein LM, Gangadharan A, Walsh LM, Nam D, Espejo AB, Singh MM, Patel KH, Lu Y, Su X, Ezhilarasan R, Gumin J, Singh S, Sulman E, Lang FF, Chandra J. Comparison of pharmacological inhibitors of lysine-specific demethylase 1 in glioblastoma stem cells reveals inhibitor-specific efficacy profiles. Frontiers in Neurology. 14: 1112207. PMID 37082446 DOI: 10.3389/fneur.2023.1112207  0.291
2012 Yang FH, Zhang B, Zhou DJ, Bie L, Tom MW, Drummond DC, Nicolaides T, Mueller S, Banerjee A, Park JW, Prados MD, James DC, Gupta N, Hashizume R, Strohbehn GW, ... ... Sulman EP, et al. LAB-EXPERIMENTAL (PRE-CLINICAL) THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 14: vi25-vi37. DOI: 10.1093/Neuonc/Nos222  0.291
2021 Kocakavuk E, Anderson KJ, Varn FS, Johnson KC, Amin SB, Sulman EP, Lolkema MP, Barthel FP, Verhaak RGW. Radiotherapy is associated with a deletion signature that contributes to poor outcomes in patients with cancer. Nature Genetics. PMID 34045764 DOI: 10.1038/s41588-021-00874-3  0.29
2020 Narayan RS, Molenaar P, Teng J, Cornelissen FMG, Roelofs I, Menezes R, Dik R, Lagerweij T, Broersma Y, Petersen N, Marin Soto JA, Brands E, van Kuiken P, Lecca MC, Lenos KJ, ... ... Sulman E, et al. A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities. Nature Communications. 11: 2935. PMID 32523045 DOI: 10.1038/S41467-020-16735-2  0.29
2019 Lassman A, Pugh S, Wang T, Aldape K, Gan H, Preusser M, Vogelbaum M, Sulman E, Won M, Zhang P, Moazami G, Macsai M, Gilbert M, Bain E, Blot V, et al. ACTR-21. A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF DEPATUXIZUMAB MAFODOTIN (ABT-414) IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFIED (AMP) NEWLY DIAGNOSED GLIOBLASTOMA (nGBM) Neuro-Oncology. 21: vi17-vi17. DOI: 10.1093/Neuonc/Noz175.064  0.288
2016 Tang M, Lan Z, Amin S, Barthel F, Raman A, Zheng S, Wang Q, Rai K, Sulman E, Verhaak R. Gent-48. Structural Variants In Gliomas Affect Regulatory Dna Elements And Cause Ectopic Gene Expression Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.353  0.287
2019 Milgrom SA, Elhalawani H, Lee J, Wang Q, Mohamed ASR, Dabaja BS, Pinnix CC, Gunther JR, Court L, Rao A, Fuller CD, Akhtari M, Aristophanous M, Mawlawi O, Chuang HH, ... Sulman EP, et al. A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma. Scientific Reports. 9: 1322. PMID 30718585 DOI: 10.1038/S41598-018-37197-Z  0.286
2015 Scheurer ME, Zhou R, Gilbert MR, Bondy ML, Sulman EP, Yuan Y, Liu Y, Vera-Bolanos E, Wendland MM, Brachman DG, Stieber VW, Komaki RR, Flickinger JC, Kenyon LC, Robins HI, et al. EPID-25GERMLINE POLYMORPHISMS IN MGMT INCREASE ABILITY TO MODEL TEMOZOLOMIDE (TMZ)-RELATED MYELOTOXICITY RISK IN PATIENTS WITH GLIOBLASTOMA (GBM) TREATED ON NRG ONCOLOGY/RTOG 0825 Neuro-Oncology. 17: v83.3-v83. DOI: 10.1093/Neuonc/Nov213.25  0.286
2020 Gangadharan A, Grasse L, Espejo A, Ezhilarasan R, Collier T, Henry V, Gumin J, Sulman E, Lang F, Chandra J. EXTH-75. IN VITRO AND IN VIVO EFFICACY OF COMBINATORIAL INHIBITION OF LSD1 AND HDACS IN PATIENT DERIVED GLIOBLASTOMA STEM CELL MODELS Neuro-Oncology. 22: ii103-ii104. DOI: 10.1093/neuonc/noaa215.429  0.284
2019 Randall J, Al Feghali K, Wefel J, Grosshans D, Dibaj S, Milton D, McAvoy S, Li J, McGovern S, McAleer M, Ghia A, Paulino A, Sulman E, Penas-Prado M, Wang J, et al. RTHP-18. PROSPECTIVE PHASE II RANDOMIZED TRIAL COMPARING PROTON THERAPY VS. PHOTON IMRT FOR NEWLY DIAGNOSED GBM: SECONDARY ANALYSIS COMPARISON OF GENDER AND NEUTROPHIL-LYMPHOCYTE RATIO (NLR) IN GBM OUTCOMES Neuro-Oncology. 21: vi213-vi213. DOI: 10.1093/Neuonc/Noz175.889  0.283
2010 Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP, Verhaak RG, Hoadley KA, Hayes DN, Perou CM, Schmidt HK, et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell. 17: 510-22. PMID 20399149 DOI: 10.1016/J.Ccr.2010.03.017  0.282
2015 Mamatjan Y, Zadeh G, Sulman E, Aldape K. EPIG-13ROBUST MGMT METHYLATION DETECTION USING 450k ARRAY IN CIMP-NEGATIVE GBM Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov214.13  0.282
2017 Mahajan A, Wang X, Ahmed S, Mcaleer MF, Weinberg JS, Li J, Brown PD, Prabhu SS, Lang FF, McGovern SL, Mccutcheon I, Sulman E, Heimberger A, Ferguson S, Ghia A, et al. RTHP-35. LOCAL RECURRENCE PATTERN OF PATIENTS ENROLLED ON A RANDOMIZED STUDY OF POST-OPERATIVE STEREOTACTIC RADIOSURGERY VS OBSERVATION FOR COMPLETELY RESECTED BRAIN METASTASIS Neuro-Oncology. 19: vi226-vi226. DOI: 10.1093/Neuonc/Nox168.917  0.28
2016 Huang T, Alvarez AA, Pangeni RP, M Horbinski C, Lu S, Kim SH, James CD, J Raizer J, A Kessler J, Brenann CW, Sulman EP, Finocchiaro G, Tan M, Nishikawa R, Lu X, et al. A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways. Nature Communications. 7: 12885. PMID 27698350 DOI: 10.1038/Ncomms12885  0.279
2017 Huang T, Wan X, Nakano I, Sulman E, Hu B, Cheng S. CBIO-13. MicroRNA-93 REGULATES TUMORGENICITY AND RESPONSES TO THERAPIES OF GLIOBLASTOMA THROUGH AUTOPHAGY PATHWAY Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.135  0.278
2017 Wu S, Gao F, Li X, Ding J, Zheng S, Martinez-Ledesma E, Feng N, Sulman E, Verhaak R, Groot Jd, Koul D, Yung WKA. Abstract 1781: EGFR amplification-A candidate predictive biomarker of PARP inhibitor Talazoparib sensitivity in gliomas Cancer Research. 77: 1781-1781. DOI: 10.1158/1538-7445.Am2017-1781  0.278
2017 Hossain M, Shifat R, Rivera-Molina Y, Puerta-Martinez F, Jiang H, Kim D, Johnson D, Bedford M, Sulman E, Lang F, Fueyo J, Gomez-Manzano C. GENE-19. TIE2-MEDIATED EPIGENETIC MODIFICATIONS REGULATE RADIORESISTANCE OF GLIOBLASTOMA Neuro-Oncology. 19: vi96-vi96. DOI: 10.1093/Neuonc/Nox168.393  0.278
2018 Zinn PO, Singh SK, Kotrotsou A, Hassan I, Thomas G, Luedi MM, Elakkad A, Elshafeey N, Idris T, Mosley J, Gumin J, Fuller GN, deGroot JF, Baladandayuthapani V, Sulman EP, et al. A co-clinical radiogenomic validation study - Conserved magnetic resonance radiomic appearance of Periostin expressing Glioblastoma in patients and xenograft models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30054278 DOI: 10.1158/1078-0432.Ccr-17-3420  0.278
1999 White PS, Sulman EP, Porter CJ, Matise TC. A comprehensive view of human chromosome 1. Genome Research. 9: 978-88. PMID 10523526 DOI: 10.1101/Gr.9.10.978  0.277
2020 Kurz S, Zan E, Gurewitz J, Cordova C, Troxel AB, Sawaged Z, Sevillano-Torres H, Silverman JS, Snuderl M, Zagzag D, Golfinos J, Kondziolka D, Sulman E. CTNI-53. SINGLE ARM, OPEN-LABEL, MULTICENTER PHASE II STUDY OF THE RADIONUCLIDE 177LU-DOTATATE (LUTATHERA) IN ADULTS WITH ADVANCED INTRACRANIAL MENINGIOMA Neuro-Oncology. 22: ii54-ii55. DOI: 10.1093/neuonc/noaa215.219  0.277
2012 Koay E, Sulman EP. Management of brain metastasis: past lessons, modern management, and future considerations. Current Oncology Reports. 14: 70-8. PMID 22071681 DOI: 10.1007/S11912-011-0205-9  0.277
2020 Patel RR, Verma V, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mainwaring W, Augustyn A, Fuller CD, Sulman EP, Yeboa DN, Chung CC, McAleer MF, Li J, Yoshor D, et al. Exclusion of Patients with Brain Metastases from Cancer Clinical Trials. Neuro-Oncology. PMID 31900480 DOI: 10.1093/Neuonc/Noz246  0.277
2016 Zhou R, Scheurer ME, Gilbert MR, Bondy M, Sulman EP, Yuan Y, Liu Y, Vera E, Wendland MM, Brachman D, Bearden J, McGovern SL, Wilson SS, Judy KD, Robins HI, et al. Polymorphisms risk modeling for vascular toxicity in patients with glioblastoma treated on NRG Oncology/RTOG 0825. Journal of Clinical Oncology. 34: 2049-2049. DOI: 10.1200/Jco.2016.34.15_Suppl.2049  0.276
2016 Pangeni R, Alvarez A, Huang T, Zhang W, Zhang Z, Sastry N, Lu S, Kessler J, Brenann C, Sulman E, Lu X, Nakano I, Hu B, Cheng S. GENT-14. GENOME WIDE METHYLOMIC AND TRANSCRIPTOMIC ANALYSES IDENTIFY EPIGENETIC SIGNATURES UNIQUELY DYSREGULATED IN GBM SUBTYPES Neuro-Oncology. 18: vi76-vi76. DOI: 10.1093/Neuonc/Now212.320  0.276
1996 Maris JM, Jensen SJ, Sulman EP, Beltinger CP, Gates K, Allen C, Biegel JA, Brodeur GM, White PS. Cloning, chromosomal localization, physical mapping, and genomic characterization of HKR3. Genomics. 35: 289-98. PMID 8661141 DOI: 10.1006/Geno.1996.0359  0.276
2021 Sulman EP, Eisenstat DD. World Cancer Day 2021 - Perspectives in Pediatric and Adult Neuro-Oncology. Frontiers in Oncology. 11: 659800. PMID 34041027 DOI: 10.3389/fonc.2021.659800  0.275
2016 Zinn PO, Singh SK, Kotrotsou A, Zandi F, Thomas G, Hatami M, Luedi MM, Elakkad A, Hassan I, Gumin J, Sulman EP, Lang FF, Colen RR. 139 Clinically Applicable and Biologically Validated MRI Radiomic Test Method Predicts Glioblastoma Genomic Landscape and Survival. Neurosurgery. 63: 156-157. PMID 27399418 DOI: 10.1227/01.Neu.0000489709.98960.E1  0.275
2014 Singh S, Burrell K, Alamsahebpour A, Koch E, Agnihotri S, Gumin J, Sulman E, Lang F, Wouters B, Aldape K, Zadeh G. MR-05GLIOMA STEM CELL SPECIFIC microRNA-mRNA INTERACTION NETWORK Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou262.5  0.274
2021 Rahman R, Sulman E, Haas-Kogan D, Cagney DN. Update on Radiation Therapy for Central Nervous System Tumors. Hematology/Oncology Clinics of North America. PMID 34711456 DOI: 10.1016/j.hoc.2021.08.006  0.272
2020 Modrek A, Eskilsson E, Ezhilarasan R, Wang Q, Goodman L, Bhat K, Le T, Barthel F, Tang M, Yang J, Long L, Gumin J, Lang F, Verhaak R, Aldape K, ... Sulman E, et al. PDPN+ Tumor Initiating, Treatment Resistant Glioblastoma Cells Promote Radiation Resistance Via PRC2 International Journal of Radiation Oncology*Biology*Physics. 108: e510. DOI: 10.1016/j.ijrobp.2020.07.1606  0.272
2016 Gabrusiewicz K, Rodriguez B, Wei J, Hashimoto Y, Healy L, Maiti S, Thomas G, Zhou S, Wang Q, Elakkad A, Liebelt B, Yaghi N, Ezhilarasan R, Huang N, Weinberg J, ... ... Sulman E, et al. Tmic-04. Glioblastoma-Associated Myeloid Cells Display Nonpolarized M0 Macrophage Phenotype Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.844  0.272
2021 Bunevicius A, Pikis S, Kondziolka D, Patel DN, Bernstein K, Sulman EP, Lee CC, Yang HC, Delabar V, Mathieu D, Cifarelli CP, Arsanious DE, Dahshan BA, Weir JS, Speckter H, et al. Stereotactic radiosurgery for glioblastoma considering tumor genetic profiles: an international multicenter study. Journal of Neurosurgery. 1-9. PMID 34740186 DOI: 10.3171/2021.7.JNS211277  0.269
2020 Silverman JS, Gurewitz J, Gunter C, Cooper B, Palermo A, Boulio L, Schafrick J, Lim WY, Karhan E, Renzullo S, Kozhaya L, Golfinos J, Sulman E, Unutmaz D, Kondziolka D. RBIO-01. PROSPECTIVE OBSERVATIONAL STUDY TO DETERMINE THE IMMUNE SYSTEM RESPONSE TO GAMMA KNIFE RADIOSURGERY FOR VESTIBULAR SCHWANNOMAS Neuro-Oncology. 22: ii192-ii192. DOI: 10.1093/neuonc/noaa215.801  0.268
2010 Colman H, Zhang L, Sulman EP, McDonald JM, Shooshtari NL, Rivera A, Popoff S, Nutt CL, Louis DN, Cairncross JG, Gilbert MR, Phillips HS, Mehta MP, Chakravarti A, Pelloski CE, et al. A multigene predictor of outcome in glioblastoma. Neuro-Oncology. 12: 49-57. PMID 20150367 DOI: 10.1093/Neuonc/Nop007  0.267
2014 Liu Y, Zhou R, Sulman E, Scheurer M, Boehling N, Gilbert M, Armstrong T, Bondy M, Wefel J. ED-17 * GENETIC MODULATION OF NEUROCOGNITIVE FUNCTION AND OUTCOMES IN GLIOMA PATIENTS Neuro-Oncology. 16: v69-v69. DOI: 10.1093/Neuonc/Nou253.17  0.265
2013 Nilsson CL, Berven F, Selheim F, Liu H, Moskal JR, Kroes RA, Sulman EP, Conrad CA, Lang FF, Andrén PE, Nilsson A, Carlsohn E, Lilja H, Malm J, Fenyö D, et al. Chromosome 19 annotations with disease speciation: a first report from the Global Research Consortium. Journal of Proteome Research. 12: 135-50. PMID 23249167 DOI: 10.1021/Pr3008607  0.265
2019 Khasraw M, McDonald KL, Rosenthal M, Lwin Z, Ashley D, Wheeler H, Barnes E, Foote M, Koh E, Sulman E, Back M, Buckland M, Sim H, Fisher L, Leonard R, et al. ACTR-24. A RANDOMIZED PHASE II TRIAL OF VELIPARIB (V), RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS (PTS) WITH UNMETHYLATED MGMT (uMGMT) GLIOBLASTOMA (GBM): THE VERTU STUDY Neuro-Oncology. 21: 18-18. DOI: 10.1093/Neuonc/Noz175.067  0.263
2010 Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H, Lasorella A, Aldape K, Califano A, Iavarone A. The transcriptional network for mesenchymal transformation of brain tumours. Nature. 463: 318-25. PMID 20032975 DOI: 10.1038/Nature08712  0.263
2017 Byers LA, Krug L, Waqar S, Dowlati A, Hann C, Chiappori A, Owonikoko T, Woo K, Bensman Y, Hurtado B, Cardnell R, Diao L, Fan Y, Fujimoto J, Rodriguez-Canales J, ... ... Sulman E, et al. MA11.07 Improved Small Cell Lung Cancer (SCLC) Response Rates with Veliparib and Temozolomide: Results from a Phase II Trial Journal of Thoracic Oncology. 12: S406-S407. DOI: 10.1016/J.Jtho.2016.11.466  0.262
2019 Khasraw M, McDonald KL, Rosenthal M, Lwin Z, Ashley DM, Wheeler H, Barnes E, Foote MC, Koh E, Sulman EP, Back M, Buckland M, Sim H, Fisher L, Leonard R, et al. A randomized phase II trial of veliparib (V), radiotherapy (RT) and temozolomide (TMZ) in patients (pts) with unmethylated MGMT (uMGMT) glioblastoma (GBM). Journal of Clinical Oncology. 37: 2011-2011. DOI: 10.1200/Jco.2019.37.15_Suppl.2011  0.261
2016 Sulman EP, Ismaila N, Chang SM. Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline. Journal of Oncology Practice. JOP2016018937. PMID 27907278 DOI: 10.1200/Jop.2016.018937  0.259
2017 Goldstein JB, Ezhilarasan R, Jaffari M, Carugo A, Draetta G, Verhaak R, Seth S, Sulman E, Futreal PA. Abstract 2916: The clonal evolution of glioblastoma Cancer Research. 77: 2916-2916. DOI: 10.1158/1538-7445.Am2017-2916  0.258
1998 White PS, Jensen SJ, Rajalingam V, Stairs D, Sulman EP, Maris JM, Biegel JA, Wooster R, Brodeur GM. Physical mapping of the CA6, ENO1, and SLC2A5 (GLUT5) genes and reassignment of SLC2A5 to 1p36.2. Cytogenetics and Cell Genetics. 81: 60-4. PMID 9691177 DOI: 10.1159/000014989  0.256
2006 Sulman EP, Schwartz DL, Morrison WH, Rosenthal DI, Chao KS, Ahamad A, Ang KK, Garden AS. 2364 : IMRT Re-Irradiation for Locoregionally Recurrent or In-Field Second Primary Head and Neck Cancer International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.773  0.256
2018 Tiwary S, Wei J, Ezhilasaran R, Sulman E, Huang S, Ferguson S. Immu-08. The Role Of Wnt Signaling On T-Cell Infiltration In Glioblastoma Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.511  0.255
2015 Nilsson CL, Mostovenko E, Lichti CF, Ruggles K, Fenyö D, Rosenbloom KR, Hancock WS, Paik YK, Omenn GS, LaBaer J, Kroes RA, Uhlén M, Hober S, Végvári Á, Andrén PE, ... Sulman EP, et al. Use of ENCODE resources to characterize novel proteoforms and missing proteins in the human proteome. Journal of Proteome Research. 14: 603-8. PMID 25369122 DOI: 10.1021/Pr500564Q  0.254
2018 Huang T, Kwon Kim C, Alvarez A, Pangeni R, Wan X, Xiao S, Shi T, Yang Y, Sastry N, Horbinski C, Lu S, Stupp R, Kessler J, Nishikawa R, Nakano I, ... Sulman E, et al. CSIG-35. MST4 PHOSPHORYLATION OF ATG4B REGULATES AUTOPHAGIC ACTIVITY, TUMORIGENICITY, AND RADIORESISTANCE IN GLIOBLASTOMA Neuro-Oncology. 20: vi50-vi51. DOI: 10.1093/Neuonc/Noy148.201  0.254
2017 Chung C, Brown PD, McAvoy S, Grosshans DR, Dibaj S, Guha-Thakurta N, Li J, McGovern SL, Mcaleer MF, Ghia A, Paulino A, Sulman E, Penas-Prado M, Wang J, de Groot J, et al. ACTR-72. A PROSPECTIVE PHASE II RANDOMIZED TRIAL TO COMPARE INTENSITY MODULATED PROTON RADIOTHERAPY (IMPT) VS. INTENSITY MODULATED RADIOTHERAPY (IMRT) FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM) Neuro-Oncology. 19: vi16-vi16. DOI: 10.1093/Neuonc/Nox168.059  0.254
2017 Yeboa D, Yu J, Huse J, Penas-Prado M, Sulman E, Contessa J. RTHP-16. PATTERNS OF TREATMENT AND OUTCOMES OF 1p19q CO-DELETED GLIOMAS Neuro-Oncology. 19: vi222-vi222. DOI: 10.1093/Neuonc/Nox168.900  0.252
2001 Sulman EP, White PS, Dumanski JP, Maris JM, Brodeur GM. Identification of candidate tumor suppressor genes in meningioma by regional expression profiling Nature Genetics. 27: 89-89. DOI: 10.1038/87318  0.252
2005 Sulman EP, Chang JY, Liao Z, Guerrero TM, Jeter M, Stevens CW, Cox JD, Komaki R. Exclusion of Elective Nodal Irradiation Does Not Decrease Local Regional Control of Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 63. DOI: 10.1016/J.Ijrobp.2005.07.387  0.251
2019 Benjamin C, Mureb M, Donahue B, Sulman E, Silverman J, Bernstein K, Kondziolka D. RADI-27. ROLE OF STEREOTACTIC RADIOSURGERY IN THE CARE OF PATIENTS WITH >/= 25 CUMULATIVE BRAIN METASTASES Neuro-Oncology Advances. 1: i27-i27. DOI: 10.1093/NOAJNL/VDZ014.119  0.25
2012 Kim JH, Charkravarti A, Wang M, Aldape K, Sulman E, Bredel M, Hegi M, Gilbert M, Curran W, Werner-Wasik M, Mehta M, Bent MJvd, Brandes AA, Taphoorn MJ, Kros JM, et al. Clin-Medical + Radiation Therapies Neuro-Oncology. 14. DOI: 10.1093/Neuonc/Nos227  0.249
2019 Fukumura K, Mao X, Song X, Fischer G, Yang J, Sulman E, Davies M, Zhang J, Huse J. BSCI-12. COMPREHENSIVE GENOMIC ANALYSIS OF BRAIN METASTASES FROM MULTIPLE CANCER TYPES Neuro-Oncology Advances. 1: i3-i3. DOI: 10.1093/noajnl/vdz014.010  0.249
2013 Adachi K, Sasaki H, Nagahisa S, Yoshida K, Hattori N, Nishiyama Y, Kawase T, Hasegawa M, Abe M, Hirose Y, Alentorn A, Marie Y, Poggioli S, Alshehhi H, Boisselier B, ... ... Sulman E, ... ... Sulman E, ... ... Sulman EP, et al. OMICS AND PROGNSTIC MARKERS Neuro-Oncology. 15: iii136-iii155. DOI: 10.1093/Neuonc/Not183  0.247
2022 Zhang ZY, Ding Y, Ezhilarasan R, Lhakhang T, Wang Q, Yang J, Modrek AS, Zhang H, Tsirigos A, Futreal A, Draetta GF, Verhaak RGW, Sulman EP. Lineage-coupled clonal capture identifies clonal evolution mechanisms and vulnerabilities of BRAF inhibition resistance in melanoma. Cell Discovery. 8: 102. PMID 36202798 DOI: 10.1038/s41421-022-00462-7  0.244
2010 Broom BM, Sulman EP, Do KA, Edgerton ME. Bagged gene shaving for the robust clustering of high-throughput data. International Journal of Bioinformatics Research and Applications. 6: 326-43. PMID 20940121 DOI: 10.1504/Ijbra.2010.035997  0.244
2007 Pelloski CE, Ballman KV, Furth AF, Zhang L, Lin E, Sulman EP, Bhat K, McDonald JM, Yung WK, Colman H, Woo SY, Heimberger AB, Suki D, Prados MD, Chang SM, et al. Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 2288-94. PMID 17538175 DOI: 10.1200/JCO.2006.08.0705  0.241
2018 Maraka S, Groves MD, Mammoser AG, Melguizo-Gavilanes I, Conrad CA, Tremont-Lukats IW, Loghin ME, O'Brien BJ, Puduvalli VK, Sulman EP, Hess KR, Aldape KD, Gilbert MR, de Groot JF, Alfred Yung WK, et al. Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma. Cancer. PMID 30359477 DOI: 10.1002/Cncr.31811  0.241
2021 Gudikote JP, Cascone T, Poteete A, Sitthideatphaiboon P, Wu Q, Morikawa N, Zhang F, Peng S, Tong P, Li L, Shen L, Nilsson M, Jones P, Sulman EP, Wang J, et al. Inhibition of nonsense-mediated decay rescues p53β/γ isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers. The Journal of Biological Chemistry. 101163. PMID 34481841 DOI: 10.1016/j.jbc.2021.101163  0.238
2016 Vera E, Scheurer M, Zhou R, Gilbert MR, Bondy M, Sulman E, Yuan Y, Liu Y, Wendland M, Brachman D, Bearden J, McGovern SL, Wilson S, Judy K, Robins HI, et al. ACTR-21. OCCURRENCE AND IMPLICATIONS OF MYELOSUPPRESSION DURING CONCURRENT THERAPY ON RTOG 0825 Neuro-Oncology. 18: vi6-vi6. DOI: 10.1093/Neuonc/Now212.020  0.237
2017 Gittleman H, Lim D, Kattan MW, Chakravarti A, Gilbert MR, Lassman AB, Lo SS, Machtay M, Sloan AE, Sulman EP, Tian D, Vogelbaum MA, Wang TJC, Penas-Prado M, Youssef E, et al. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. Neuro-Oncology. 19: 669-677. PMID 28453749 DOI: 10.1093/Neuonc/Now208  0.235
2016 Gittleman H, Lim D, Kattan MW, Chakravarti A, Gilbert MR, Lassman AB, Lo SS, Machtay M, Sloan AE, Sulman EP, Tian D, Vogelbaum MA, Wang TJ, Penas-Prado M, Youssef E, et al. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. Neuro-Oncology. PMID 27663387 DOI: 10.1200/Jco.2016.34.15_Suppl.2007  0.235
1998 Sulman EP, Dumanski JP, White PS, Zhao H, Maris JM, Mathiesen T, Bruder C, Cnaan A, Brodeur GM. Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity. Cancer Research. 58: 3226-30. PMID 9699646  0.234
2015 Olar A, Wani KM, Alfaro-Munoz KD, Heathcock LE, van Thuijl HF, Gilbert MR, Armstrong TS, Sulman EP, Cahill DP, Vera-Bolanos E, Yuan Y, Reijneveld JC, Ylstra B, Wesseling P, Aldape KD. IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas. Acta Neuropathologica. 129: 585-96. PMID 25701198 DOI: 10.1007/S00401-015-1398-Z  0.234
1998 Hogarty MD, White PS, Sulman EP, Brodeur GM. Mononucleotide repeat instability is infrequent in neuroblastoma. Cancer Genetics and Cytogenetics. 106: 140-3. PMID 9797779 DOI: 10.1016/S0165-4608(98)00050-8  0.23
2017 Audia A, Das A, Mukheef F, Zhang Z, Sulman E, Bhat K. Cbio-08. Directed Neuronal Differentiation In Gbm By Suppression Of Taz Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.130  0.226
2019 Ludmir EB, Mahajan A, Ahern V, Ajithkumar T, Alapetite C, Bernier-Chastagner V, Bindra RS, Bishop AJ, Bolle S, Brown PD, Carrie C, Chalmers AJ, Chang EL, Chung C, Dieckmann K, ... ... Sulman EP, et al. Assembling the brain trust: the multidisciplinary imperative in neuro-oncology. Nature Reviews. Clinical Oncology. PMID 31150024 DOI: 10.1038/S41571-019-0235-Z  0.226
2021 Sim HW, McDonald KL, Lwin Z, Barnes EH, Rosenthal M, Foote MC, Koh ES, Back M, Wheeler H, Sulman EP, Buckland ME, Fisher L, Leonard R, Hall M, Ashley DM, et al. A randomized phase II trial of veliparib, radiotherapy and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study. Neuro-Oncology. PMID 33984151 DOI: 10.1093/neuonc/noab111  0.226
2020 Dasgupta P, Gumin J, Pettazzoni P, Barthel F, Deem A, Dey P, Huang-Hobbs E, Sulman E, Verhaak R, Lang F, Draetta G. EPCO-11. IN VIVO FUNCTIONAL GENOMIC SCREEN IDENTIFIES WISP1 AS AN OVEREXPRESSED DRIVER OF GLIOBLASTOMA Neuro-Oncology. 22: ii71-ii71. DOI: 10.1093/neuonc/noaa215.290  0.225
2023 Galbraith K, Vasudevaraja V, Serrano J, Shen G, Tran I, Abdallat N, Wen M, Patel S, Movahed-Ezazi M, Faustin A, Spino-Keeton M, Roberts LG, Maloku E, Drexler SA, Liechty BL, ... ... Sulman EP, et al. Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing. Neuro-Oncology Advances. 5: vdad076. PMID 37476329 DOI: 10.1093/noajnl/vdad076  0.225
2014 Beiko J, Suki D, Hess KR, Fox BD, Cheung V, Cabral M, Shonka N, Gilbert MR, Sawaya R, Prabhu SS, Weinberg J, Lang FF, Aldape KD, Sulman EP, Rao G, et al. IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection. Neuro-Oncology. 16: 81-91. PMID 24305719 DOI: 10.1093/Neuonc/Not159  0.225
2001 White PS, Thompson PM, Seifried BA, Sulman EP, Jensen SJ, Guo C, Maris JM, Hogarty MD, Allen C, Biegel JA, Matise TC, Gregory SG, Reynolds CP, Brodeur GM. Comprehensive analysis of chromosome 1p deletions in neuroblastoma Medical and Pediatric Oncology. 36: 32-36. PMID 11464900 DOI: 10.1002/1096-911X(20010101)36:1<32::Aid-Mpo1009>3.0.Co;2-0  0.223
1995 Ikegaki N, Tang XX, Liu XG, Biegel JA, Allen C, Yoshioka A, Sulman EP, Brodeur GM, Pleasure DE. Molecular characterization and chromosomal localization of DRT (EPHT3): a developmentally regulated human protein-tyrosine kinase gene of the EPH family. Human Molecular Genetics. 4: 2033-45. PMID 8589679 DOI: 10.1093/hmg/4.11.2033  0.22
2004 Sulman EP, White PS, Brodeur GM. Genomic annotation of the meningioma tumor suppressor locus on chromosome 1p34. Oncogene. 23: 1014-20. PMID 14749765 DOI: 10.1038/sj.onc.1206623  0.218
2020 Liu E, Kurz SC, Ahn J, Sulman EP. Prevalence and temporal trends of prescription drug use in cancer survivors: A population study, 2001 to 2016. Journal of Clinical Oncology. 38: 12023-12023. DOI: 10.1200/Jco.2020.38.15_Suppl.12023  0.218
2016 Huang T, Alvarez A, Pangeni R, Horbinski C, Lu S, James CD, Raizer J, Brenann C, Sulman E, Finocchiaro G, Tan M, Nishikawa R, Lu X, Nakano I, Hu B, et al. CSIG-08. A REGULATORY CIRCUIT OF miR-125b/miR-20b AND Wnt SIGNALING CONTROLS GBM PHENOTYPES THROUGH FZD6-MEDIATED PATHWAYS Neuro-Oncology. 18: vi42-vi42. DOI: 10.1093/Neuonc/Now212.169  0.216
2013 Aaberg-Jessen C, Fogh L, Halle B, Jensen V, Brunner N, Kristensen BW, Abe T, Momii Y, Watanabe J, Morisaki I, Natsume A, Wakabayashi T, Fujiki M, Aldaz B, Fabius AWM, ... ... Sulman E, et al. EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 15: iii37-iii61. DOI: 10.1093/Neuonc/Not176  0.214
2000 Hogarty MD, Liu X, Thompson PM, White PS, Sulman EP, Maris JM, Brodeur GM. BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification. Medical and Pediatric Oncology. 35: 559-62. PMID 11107117 DOI: 10.1002/1096-911X(20001201)35:6<559::Aid-Mpo14>3.0.Co;2-J  0.213
2017 Milgrom S, Lee J, Wang Q, Court L, Ng A, Pinnix C, Dabaja B, Akhtari M, Aristophanous M, Mawlawi O, Andraos T, Lee H, Hagemeister F, Oki Y, Fanale M, ... Sulman E, et al. Importance of PET-CT Radiomics Features in Outcomes Prognostication for Mediastinal Hodgkin Lymphoma International Journal of Radiation Oncology*Biology*Physics. 99: S63. DOI: 10.1016/J.Ijrobp.2017.06.156  0.213
2021 Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, Dunn IF, Gaspar LE, Gatson NTN, Gondi V, Jordan JT, Lassman AB, Maues J, Mohile N, Redjal N, ... ... Sulman E, et al. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2102314. PMID 34932393 DOI: 10.1200/JCO.21.02314  0.213
2023 Mashiach E, Alzate JD, De Nigris Vasconcellos F, Bernstein K, Donahue BR, Schnurman Z, Gurewitz J, Rotman LE, Adams S, Meyers M, Oratz R, Novik Y, Kwa MJ, Silverman JS, Sulman EP, et al. Long-term Survival From Breast Cancer Brain Metastases in the Era of Modern Systemic Therapies. Neurosurgery. PMID 37581437 DOI: 10.1227/neu.0000000000002640  0.211
2021 Wefel JS, Zhou R, Sulman EP, Boehling NS, Armstrong GN, Tsavachidis S, Liang FW, Etzel CJ, Kahalley LS, Small BJ, Scheurer ME, Bondy ML, Liu Y. Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients. Journal of Neuro-Oncology. PMID 34817796 DOI: 10.1007/s11060-021-03905-5  0.21
2017 Zhang S, Zhao BS, Zhou A, Lin K, Zheng S, Lu Z, Chen Y, Sulman EP, Xie K, Bögler O, Majumder S, He C, Huang S. m(6)A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. Cancer Cell. PMID 28344040 DOI: 10.1016/J.Ccell.2017.02.013  0.209
2011 Parikh N, Likhacheva A, Pinnix C, Allen P, McAleer M, Chiu M, Sulman E, Mahajan A, Prabhu S, Chang E. Radiosurgery in Patients with “Radioresistant” Brain Metastases: Outcomes and Prognosis International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.1920  0.209
2023 Schnurman Z, Mashiach E, Link KE, Donahue B, Sulman E, Silverman J, Golfinos JG, Oermann EK, Kondziolka D. Causes of Death in Patients With Brain Metastases. Neurosurgery. PMID 37255296 DOI: 10.1227/neu.0000000000002542  0.208
2022 Yang J, Wang Q, Zhang ZY, Long L, Ezhilarasan R, Karp JM, Tsirigos A, Snuderl M, Wiestler B, Wick W, Miao Y, Huse JT, Sulman EP. DNA methylation-based epigenetic signatures predict somatic genomic alterations in gliomas. Nature Communications. 13: 4410. PMID 35906213 DOI: 10.1038/s41467-022-31827-x  0.206
2017 Olmez I, Love S, Xiao A, Manigat L, Randolph P, McKenna BD, Neal BP, Boroda S, Li M, Brenneman B, Abounader R, Floyd D, Lee J, Nakano I, Godlewski J, ... ... Sulman EP, et al. Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha. Neuro-Oncology. PMID 29048560 DOI: 10.1093/Neuonc/Nox119  0.204
2021 Khan S, Mahalingam R, Sen S, Martinez-Ledesma E, Khan A, Gandy K, Lang FF, Sulman EP, Alfaro-Munoz KD, Majd NK, Balasubramaniyan V, de Groot JF. Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells. Cancers. 13. PMID 34771447 DOI: 10.3390/cancers13215284  0.201
1995 White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hilliard C, Valentine MB, Look AT, Enomoto H, Sakiyama S, Brodeur GM. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proceedings of the National Academy of Sciences of the United States of America. 92: 5520-4. PMID 7777541 DOI: 10.1073/pnas.92.12.5520  0.201
2013 Welsh JW, Komaki R, Amini A, Munsell MF, Unger W, Allen PK, Chang JY, Wefel JS, McGovern SL, Garland LL, Chen SS, Holt J, Liao Z, Brown P, Sulman E, et al. Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 895-902. PMID 23341526 DOI: 10.1200/JCO.2011.40.1174  0.2
1996 Maris JM, Kyemba SM, Rebbeck TR, White PS, Sulman EP, Jensen SJ, Allen C, Biegel JA, Yanofsky RA, Feldman GL, Brodeur GM. Familial predisposition to neuroblastoma does not map to chromosome band 1p36. Cancer Research. 56: 3421-5. PMID 8758905  0.197
1995 Beltinger CP, White PS, Sulman EP, Maris JM, Brodeur GM. No CDKN2 mutations in neuroblastomas. Cancer Research. 55: 2053-5. PMID 7743501  0.196
2023 Berger A, Mullen R, Bernstein K, Alzate JD, Silverman JS, Sulman EP, Donahue BR, Chachoua A, Shum E, Velcheti V, Sabari J, Golfinos JG, Kondziolka D. Extended Survival in Patients With Non-Small-Cell Lung Cancer-Associated Brain Metastases in the Modern Era. Neurosurgery. PMID 36722962 DOI: 10.1227/neu.0000000000002372  0.193
2001 White PS, Thompson PM, Seifried BA, Sulman EP, Jensen SJ, Guo C, Maris JM, Hogarty MD, Allen C, Biegel JA, Matise TC, Gregory SG, Reynolds CP, Brodeur GM. Detailed molecular analysis of 1p36 in neuroblastoma. Medical and Pediatric Oncology. 36: 37-41. PMID 11464901 DOI: 10.1002/1096-911X(20010101)36:1<37::Aid-Mpo1010>3.0.Co;2-L  0.192
2014 Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S, Won M, Jeraj R, Brown PD, Jaeckle KA, Schiff D, Stieber VW, ... ... Sulman EP, et al. A randomized trial of bevacizumab for newly diagnosed glioblastoma. The New England Journal of Medicine. 370: 699-708. PMID 24552317 DOI: 10.1056/Nejmoa1308573  0.191
2021 Al Feghali KA, Randall JW, Liu DD, Wefel JS, Brown PD, Grosshans DR, McAvoy SA, Farhat MA, Li J, McGovern SL, McAleer MF, Ghia AJ, Paulino AC, Sulman EP, Penas-Prado M, et al. Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment. Neuro-Oncology Advances. 3: vdab073. PMID 34337411 DOI: 10.1093/noajnl/vdab073  0.191
2000 Hogarty MD, Liu X, Guo C, Thompson PM, Weiss MJ, White PS, Sulman EP, Brodeur GM, Maris JM. Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas. Medical and Pediatric Oncology. 35: 512-5. PMID 11107105 DOI: 10.1002/1096-911X(20001201)35:6<512::Aid-Mpo2>3.0.Co;2-D  0.188
2023 Alzate JD, Mashiach E, Berger A, Bernstein K, Mullen R, Nigris Vasconcellos F, Qu T, Silverman JS, Donahue BR, Cooper BT, Sulman EP, Golfinos JG, Kondziolka D. Low-Dose Radiosurgery for Brain Metastases in the Era of Modern Systemic Therapy. Neurosurgery. PMID 37326435 DOI: 10.1227/neu.0000000000002556  0.188
2021 Puca F, Yu F, Bartolacci C, Pettazzoni P, Carugo A, Huang-Hobbs E, Liu J, Zanca C, Carbone F, Del Poggetto E, Gumin J, Dasgupta P, Seth S, Srinivasan S, Lang FF, ... Sulman EP, et al. Medium-chain acyl CoA dehydrogenase protects mitochondria from lipid peroxidation in glioblastoma. Cancer Discovery. PMID 34039636 DOI: 10.1158/2159-8290.CD-20-1437  0.187
2022 Berger A, Bernstein K, Alzate JD, Mullen R, Silverman JS, Sulman EP, Donahue BR, Pavlick AC, Gurewitz J, Mureb M, Mehnert J, Madden K, Palermo A, Weber JS, Golfinos JG, et al. Significant survival improvements for patients with melanoma brain metastases: can we reach cure in the current era? Journal of Neuro-Oncology. PMID 35665462 DOI: 10.1007/s11060-022-04036-1  0.186
1997 Maris JM, Jensen J, Sulman EP, Beltinger CP, Allen C, Biegel JA, Brodeur GM, White PS. Human Krüppel-related 3 (HKR3): a candidate for the 1p36 neuroblastoma tumour suppressor gene? European Journal of Cancer (Oxford, England : 1990). 33: 1991-6. PMID 9516840 DOI: 10.1016/S0959-8049(97)00279-7  0.184
2009 Sulman EP, Schwartz DL, Le TT, Ang KK, Morrison WH, Rosenthal DI, Ahamad A, Kies M, Glisson B, Weber R, Garden AS. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. International Journal of Radiation Oncology, Biology, Physics. 73: 399-409. PMID 18556144 DOI: 10.1016/J.Ijrobp.2008.04.021  0.183
2020 Lee WC, Reuben A, Hu X, McGranahan N, Chen R, Jalali A, Negrao MV, Hubert SM, Tang C, Wu CC, Lucas AS, Roh W, Suda K, Kim J, Tan AC, ... ... Sulman EP, et al. Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity. Genome Biology. 21: 271. PMID 33148332 DOI: 10.1186/s13059-020-02175-0  0.182
2022 Danussi C, Bose P, Parthasarathy PT, Silberman PC, Van Arnam JS, Vitucci M, Tang OY, Heguy A, Wang Y, Chan TA, Riggins GJ, Sulman EP, Lang FF, Creighton CJ, Deneen B, et al. Author Correction: Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling. Nature Communications. 13: 190. PMID 34987156 DOI: 10.1038/s41467-021-27820-5  0.181
2015 Jiang W, Rodriguez Y, Kim B, Tang C, Haydu L, Mahajan A, Davies M, Hwu P, Sulman E, Brown P, Li J. Temporally-Dependent Intracranial Control of Melanoma Brain Metastasis by Stereotactic Radiation Therapy in Patients Treated With Immune Checkpoint Blockade International Journal of Radiation Oncology*Biology*Physics. 93: S57. DOI: 10.1016/j.ijrobp.2015.07.137  0.181
2013 Ambady P, Holdhoff M, Ferrigno C, Grossman S, Anderson MD, Liu D, Conrad C, Penas-Prado M, Gilbert MR, Yung AWK, Groot Jd, Aoki T, Nishikawa R, Sugiyama K, Nonoguchi N, ... ... Sulman E, et al. Neuro/Medical Oncology Neuro-Oncology. 15: 120-120. DOI: 10.1093/Neuonc/Not182  0.181
2015 Luedi M, Singh S, Hassan I, Gumin J, Sulman E, Lang F, Colen R, Zinn P. ATPS-11DEXAMETHASONE INDUCES A MESENCHYMAL SHIFT IN GLIOBLASTOMA STEM CELLS Neuro-Oncology. 17: v20.3-v20. DOI: 10.1093/NEUONC/NOV204.11  0.18
2016 Sahm F, Schrimpf D, Olar A, Koelsche C, Reuss D, Bissel J, Kratz A, Capper D, Schefzyk S, Hielscher T, Wang Q, Sulman EP, Adeberg S, Koch A, Okuducu AF, et al. TERT Promoter Mutations and Risk of Recurrence in Meningioma. Journal of the National Cancer Institute. 108. PMID 26668184 DOI: 10.1093/Jnci/Djv377  0.178
2024 Berger A, Mullen R, Bernstein K, Mashiach E, Meng Y, Silverman JS, Sulman EP, Golfinos JG, Kondziolka D. Volumetric growth rate of incidentally found meningiomas on immunotherapy. Journal of Neuro-Oncology. PMID 38194196 DOI: 10.1007/s11060-023-04558-2  0.176
2020 Buxton M, Alexander B, Berry D, Cavenee W, Colman H, de Groot J, Ellingson B, Gordon G, Khasraw M, Lassman A, Lee W, Lim M, Mellinghoff I, Perry J, Sulman E, et al. RTID-11. GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA Neuro-Oncology. 22: ii195-ii196. DOI: 10.1093/neuonc/noaa215.816  0.176
2021 Kavi A, Gurewitz J, Benjamin C, Silverman J, Bernstein K, Mureb M, Oh C, Sulman EP, Donahue B, Kondziolka D. Hippocampal sparing in patients receiving radiosurgery for ≥ 25 brain metastases. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 34052342 DOI: 10.1016/j.radonc.2021.05.019  0.175
2016 Gabrusiewicz K, Rodriguez B, Wei J, Hashimoto Y, Healy LM, Maiti SN, Thomas G, Zhou S, Wang Q, Elakkad A, Liebelt BD, Yaghi NK, Ezhilarasan R, Huang N, Weinberg JS, ... ... Sulman EP, et al. Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. Jci Insight. 1. PMID 26973881 DOI: 10.1172/Jci.Insight.85841  0.175
2019 Ma J, Benitez JA, Li J, Miki S, Ponte de Albuquerque C, Galatro T, Orellana L, Zanca C, Reed R, Boyer A, Koga T, Varki NM, Fenton TR, Nagahashi Marie SK, Lindahl E, ... ... Sulman EP, et al. Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair. Cancer Cell. 35: 816. PMID 31085179 DOI: 10.1016/j.ccell.2019.04.011  0.175
2011 Sharp H, Skinner H, Chang E, Settle S, Sulman E, Grosshans D, McAleer M, Brown P, de Groot J, Mahajan A. Concurrent Temozolomide and Radiation in Elderly Patients with Glioblastoma: A Retrospective Analysis International Journal of Radiation Oncology*Biology*Physics. 81: S278-S279. DOI: 10.1016/J.Ijrobp.2011.06.482  0.174
1995 Maris JM, White PS, Beltinger CP, Sulman EP, Castleberry RP, Shuster JJ, Look AT, Brodeur GM. Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Cancer Research. 55: 4664-9. PMID 7553646  0.173
2014 de Groot J, Thomas C, Piao Y, Nguyen N, Drewry D, Zuercher B, Verhaak R, Stephan C, Sulman EP, Lang F, Yung A. HIGH-THROUGHPUT SCREENING OF GLIOMA STEM CELL LINES FOR DRUG STRUCTURE- AND GENOTYPE-CORRELATED SENSITIVITY TO A PANEL OF TYROSINE KINASE INHIBITORS Neuro-Oncology. 16: iii32-iii32. DOI: 10.1093/NEUONC/NOU208.36  0.172
2021 Bunevicius A, Pikis S, Kondziolka D, Patel DN, Bernstein K, Sulman EP, Lee CC, Yang HC, Delabar V, Mathieu D, Cifarelli CP, Arsanious DE, Dahshan BA, Weir JS, Speckter H, et al. Stereotactic radiosurgery for IDH wild type glioblastoma: an international, multicenter study. Journal of Neuro-Oncology. PMID 34797526 DOI: 10.1007/s11060-021-03883-8  0.171
2022 Scheurer ME, Zhou R, Gilbert MR, Bondy ML, Sulman EP, Yuan Y, Liu Y, Vera E, Wendland MM, Youssef EF, Stieber VW, Komaki RR, Flickinger JC, Kenyon LC, Robins HI, et al. Germline polymorphisms in associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825. Neuro-Oncology Advances. 4: vdac152. PMID 36299794 DOI: 10.1093/noajnl/vdac152  0.171
1996 Beltinger CP, White PS, Maris JM, Sulman EP, Jensen SJ, LePaslier D, Stallard BJ, Goeddel DV, de Sauvage FJ, Brodeur GM. Physical mapping and genomic structure of the human TNFR2 gene. Genomics. 35: 94-100. PMID 8661109 DOI: 10.1006/Geno.1996.0327  0.17
2024 Galbraith K, Garcia M, Wei S, Chen A, Schroff C, Serrano J, Pacione D, Placantonakis DG, William CM, Faustin A, Zagzag D, Barbaro M, Eibl MDPGP, Shirahata M, Reuss D, ... ... Sulman EP, et al. Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas. Neuro-Oncology. PMID 38243818 DOI: 10.1093/neuonc/noae009  0.169
2022 Berger A, Alzate JD, Bernstein K, Mullen R, McMenomey S, Jethanemest D, Friedmann DR, Smouha E, Sulman EP, Silverman JS, Roland JT, Golfinos JG, Kondziolka D. Modern Hearing Preservation Outcomes After Vestibular Schwannoma Stereotactic Radiosurgery. Neurosurgery. PMID 35973088 DOI: 10.1227/neu.0000000000002090  0.167
1997 White PS, Maris JM, Sulman EP, Jensen SJ, Kyemba SM, Beltinger CP, Allen C, Kramer DL, Biegel JA, Brodeur GM. Molecular analysis of the region of distal 1p commonly deleted in neuroblastoma. European Journal of Cancer (Oxford, England : 1990). 33: 1957-61. PMID 9516832 DOI: 10.1016/S0959-8049(97)00311-0  0.164
2021 London D, Patel DN, Donahue B, Navarro RE, Gurewitz J, Silverman JS, Sulman E, Bernstein K, Palermo A, Golfinos JG, Sabari JK, Shum E, Velcheti V, Chachoua A, Kondziolka D. The incidence and predictors of new brain metastases in patients with non-small cell lung cancer following discontinuation of systemic therapy. Journal of Neurosurgery. 1-11. PMID 34891140 DOI: 10.3171/2021.9.JNS212150  0.162
2013 Dignam J, Won M, Blumenthal DT, Vogelbaum MA, Aldape KD, Colman H, Chakravarti A, Jeraj R, Armstrong TS, Wefel JS, Brown PD, Jaeckle KA, Schiff D, Atkins JN, Brachman D, ... ... Sulman EP, et al. RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1. PMID 28136057 DOI: 10.1200/jco.2013.31.18_suppl.1  0.161
2019 Al Feghali K, Randall J, Wefel J, Guha-Thakurta N, Grosshans D, Dibej S, McAvoy S, Li J, McGovern S, McAleer M, Ghia A, Paulino A, Sulman E, Penas-Prado M, Wang J, et al. Prospective Phase II Randomized Trial Comparing Proton Therapy vs. IMRT for Newly Diagnosed GBM: Secondary Analysis Comparison of Progression Free Survival between Clinical Radiological Assessment vs. Response Assessment in Neuro-Oncology (RANO) International Journal of Radiation Oncology*Biology*Physics. 105: S139. DOI: 10.1016/J.Ijrobp.2019.06.132  0.156
2022 Liu EK, Vasudevaraja V, Sviderskiy VO, Feng Y, Tran I, Serrano J, Cordova C, Kurz SC, Golfinos JG, Sulman EP, Orringer DA, Placantonakis D, Possemato R, Snuderl M. Association of hyperglycemia and molecular subclass on survival in IDH-wildtype glioblastoma. Neuro-Oncology Advances. 4: vdac163. PMID 36382106 DOI: 10.1093/noajnl/vdac163  0.155
2014 Gilbert MR, Sulman EP, Mehta MP. Bevacizumab for newly diagnosed glioblastoma. The New England Journal of Medicine. 370: 2048-9. PMID 24849088 DOI: 10.1056/NEJMc1403303  0.154
2020 Li J, Ludmir E, Wang Y, Guha-Thakurta N, McAleer M, Settle S, Yeboa D, Ghia A, McGovern S, Chung C, Woodhouse K, Briere T, Sullaway C, Liu D, Rao G, ... ... Sulman E, et al. Stereotactic Radiosurgery versus Whole-brain Radiation Therapy for Patients with 4-15 Brain Metastases: A Phase III Randomized Controlled Trial International Journal of Radiation Oncology*Biology*Physics. 108: S21-S22. DOI: 10.1016/j.ijrobp.2020.07.2108  0.152
2023 Kurz SC, Zan E, Cordova C, Troxel AB, Barbaro M, Silverman JS, Snuderl M, Zagzag D, Kondziolka D, Golfinos JG, Chi AS, Sulman EP. Evaluation of the SSTR2-targeted radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as imaging biomarker in patients with intracranial meningioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 38048045 DOI: 10.1158/1078-0432.CCR-23-2533  0.152
2011 Pinnix CC, Likhacheva A, Parikh N, Chiu MSK, Allen PK, Mahajan A, McAleer M, Sulman EP, Guha-Thakurta N, Chang E. Identification of Clinical Factors to Help Predict for Early Rapid MRI Progression (ERMP) of Brain Metastasis Patients Undergoing Gamma Knife Radiosurgery International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.1903  0.152
2016 Sarkaria J, Decker P, Remonde D, Kosel M, Carlson B, Schroeder M, Bakken K, Sulman E, Eckel Passow J. Experimental design recommendations for PDX pre-clinical trials: Reanalysis of radiation and temozolomide orthotopic survival data in GBM models European Journal of Cancer. 69: S58. DOI: 10.1016/S0959-8049(16)32761-7  0.151
2022 Liu EK, Oh C, Kondziolka D, Sulman EP. Risk of Second Primary Neoplasms of the Central Nervous System. Advances in Radiation Oncology. 7: 100969. PMID 35814854 DOI: 10.1016/j.adro.2022.100969  0.149
2020 Kocakavuk E, Anderson K, Johnson K, Varn F, Amin S, Sulman E, Barthel F, Verhaak R. 2MO Radiotherapy in cancer is associated with a deletion signature that contributes to poor patient outcomes Annals of Oncology. 31: S1217. DOI: 10.1016/j.annonc.2020.08.2161  0.149
2022 Schiff D, Messersmith H, Brastianos PK, Brown PD, Burri S, Dunn IF, Gaspar LE, Gondi V, Jordan JT, Maues J, Mohile N, Redjal N, Stevens GHJ, Sulman EP, van den Bent M, et al. Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2200333. PMID 35561283 DOI: 10.1200/JCO.22.00333  0.141
1996 Kuroda H, White PS, Sulman EP, Manohar CF, Reiter JL, Cohn SL, Brodeur GM. Physical mapping of the DDX1 gene to 340 kb 5' of MYCN. Oncogene. 13: 1561-5. PMID 8875996  0.14
2016 Gittleman HR, Lim D, Kattan M, Chakravarti A, Gilbert MR, Lassman AB, Lo SS, Machtay M, Sloan AE, Sulman EP, Tian D, Vogelbaum MA, Wang TJ, Penas-Prado M, Youssef E, et al. An Independently Validated Nomogram for Individualized Estimation of Survival Among Patients With Newly Diagnosed Glioblastoma: NRG Oncology/RTOG 0525 and 0825. International Journal of Radiation Oncology, Biology, Physics. 96: S92. PMID 27676053 DOI: 10.1016/j.ijrobp.2016.06.231  0.14
2017 Armstrong TS, Gilbert MR, Bondy M, Sulman E, Yuan Y, Zhou R, Vera E, Wendland M, Pugh S, Scheurer M. OS05.6 Final risk model for Temozolomide (TMZ)-Myelotoxicity in patients with Glioblastoma treated on NRG Oncology’s RTOG 0825 Neuro-Oncology. 19: iii10-iii10. DOI: 10.1093/Neuonc/Nox036.033  0.138
2014 Zhou R, Scheurer M, Vera-Bolanos E, Gilbert M, Bondy M, Sulman E, Hilsenbeck S, Wendland M, Brachman D, Roof K, Komaki R, Deutsch M, Andrews D, Anderson B, Lee RJ, et al. CN-21 * RISK MODELING FOR TEMOZOLOMIDE (TMZ)-MYELOTOXICITY IN PATIENTS WITH GLIOBLASTOMA TREATED ON RTOG 0825 Neuro-Oncology. 16: v50-v50. DOI: 10.1093/Neuonc/Nou243.21  0.136
2023 Wefel JS, Deshmukh S, Brown PD, Grosshans DR, Sulman EP, Cerhan JH, Mehta MP, Khuntia D, Shi W, Mishra MV, Suh JH, Laack NN, Chen Y, Curtis AA, Laba JM, et al. Impact of Apolipoprotein E (APOE) Genotype on Neurocognitive Function (NCF) in Patients with Brain Metastasis (BM): An Analysis of NRG Oncology's RTOG 0614. International Journal of Radiation Oncology, Biology, Physics. PMID 38101486 DOI: 10.1016/j.ijrobp.2023.12.004  0.136
2021 Brown PD, Chung C, Liu DD, McAvoy S, Grosshans D, Al Feghali K, Mahajan A, Li J, McGovern SL, McAleer MF, Ghia AJ, Sulman EP, Penas-Prado M, de Groot JF, Heimberger AB, et al. A Prospective Phase II Randomized Trial of Proton Radiotherapy vs. Intensity Modulated Radiotherapy for Patients with Newly Diagnosed Glioblastoma. Neuro-Oncology. PMID 33647972 DOI: 10.1093/neuonc/noab040  0.136
2018 Bishop AJ, Tran KT, Allen PK, Mahajan A, McAleer MF, Li J, Ghia AJ, Sulman EP, Yeboa DN, DeMonte F, Raza SM, Grosshans DR, McGovern SL. Risk of Visual Toxicity Following Fractionated Proton vs Photon Radiation Therapy for Patients with Meningiomas International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.722  0.134
1997 Maris JM, Kyemba SM, Rebbeck TR, White PS, Sulman EP, Jensen SJ, Allen C, Biegel JA, Brodeur GM. Molecular genetic analysis of familial neuroblastoma. European Journal of Cancer (Oxford, England : 1990). 33: 1923-8. PMID 9516825 DOI: 10.1016/S0959-8049(97)00265-7  0.133
2020 Modrek A, Ezhilarasan R, Hyslop B, Sulman E. Analysis Of 84 Matched Pre-Operative And Post-Treatment Recurrent Glioblastoma Specimens Reveals Dysregulation Of DNA Methylation At CTCF Enriched Regulatory Sites International Journal of Radiation Oncology*Biology*Physics. 108: e718. DOI: 10.1016/j.ijrobp.2020.07.095  0.133
1997 Sulman EP, Tang XX, Allen C, Biegel JA, Pleasure DE, Brodeur GM, Ikegaki N. ECK, a human EPH-related gene, maps to 1p36.1, a common region of alteration in human cancers. Genomics. 40: 371-4. PMID 9119409 DOI: 10.1006/geno.1996.4569  0.132
2016 Zinn PO, Singh SK, Kotrotsou A, Zandi F, Thomas G, Hatami M, Luedi MM, Elakkad A, Hassan I, Gumin J, Sulman EP, Lang FF, Colen RR. 139 Clinically Applicable and Biologically Validated MRI Radiomic Test Method Predicts Glioblastoma Genomic Landscape and Survival. Neurosurgery. 63: 156-157. PMID 28175417 DOI: 10.1227/01.neu.0000489709.98960.e1  0.132
2017 Chiu G, Kesler S, Wefel J, Sulman E, Lang F, Grosshans D, Ezhilarasan R, Liu H, Boukelmoune N, Kingsley C, Rao V, Gumin J, Ahmed S, Shpall E, Kavelaars A, et al. Intranasal administration of human mesenchymal stem cells promote recovery from chemoradiation-induced cognitive and functional deficit in mice Brain, Behavior, and Immunity. 66: e25. DOI: 10.1016/J.Bbi.2017.07.097  0.131
2023 Sulman EP, Eisenstat DD. Editorial: Insights in neuro-oncology and neurosurgical oncology: 2021. Frontiers in Oncology. 12: 1121113. PMID 36733357 DOI: 10.3389/fonc.2022.1121113  0.127
2017 Mahajan A, Ahmed S, McAleer MF, Weinberg JS, Li J, Brown P, Settle S, Prabhu SS, Lang FF, Levine N, McGovern S, Sulman E, McCutcheon IE, Azeem S, Cahill D, et al. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. The Lancet. Oncology. PMID 28687375 DOI: 10.1016/S1470-2045(17)30414-X  0.126
2011 Mehta M, Wang M, Aldape K, Sulman E, Stupp R, Jaeckle K, Blumenthal D, Erridge S, Curran W, Gilbert M. Clinical, Molecular, and Molecular-Clinical Profile (MCP) Exploratory Subset Analysis of RTOG 0525: a Phase III Trial Comparing Standard (std) Adjuvant Temozolomide (TMZ) with a Dose-dense (dd) Schedule for Glioblastoma (GBM) European Journal of Cancer. 47: 10. DOI: 10.1016/S0959-8049(11)70117-4  0.125
1997 Reddy UR, Phatak S, Allen C, Nycum LM, Sulman EP, White PS, Biegel JA. Localization of the human Ror1 gene (NTRKR1) to chromosome 1p31-p32 by fluorescence in situ hybridization and somatic cell hybrid analysis. Genomics. 41: 283-5. PMID 9143508 DOI: 10.1006/geno.1997.4653  0.116
2018 Tran KT, McGovern SL, Allen PK, Mahajan A, McAleer MF, Li J, Ghia AJ, Sulman EP, Yeboa DN, DeMonte F, Raza SM, Grosshans DR, Bishop AJ. Similar Local Control Rates for Patients with Meningiomas Treated with Proton Therapy vs. IMRT International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1082  0.115
2012 Chakravarti A, Wang M, Aldape K, Sulman E, Bredel M, Hegi M, Gilbert M, Curran W, Werner-Wasik M, Mehta M. A Revised RTOG Recursive Partitioning Analysis (RPA) Model for Glioblastoma Based Upon Multiplatform Biomarker Profiles International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.013  0.108
2021 Bagley SJ, Kothari S, Rahman R, Lee EQ, Dunn GP, Galanis E, Chang SM, Nabors LB, Ahluwalia MS, Stupp R, Mehta MP, Reardon DA, Grossman SA, Sulman EP, Sampson JH, et al. Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34561269 DOI: 10.1158/1078-0432.CCR-21-2750  0.106
2019 Yeboa D, Yu J, Liao K, Huse J, Penas-Prado M, Kann B, Sulman E, Grosshans D, Contessa J. OC-0165 Patterns of treatment and outcomes for 1p19q co-deleted gliomas Radiotherapy and Oncology. 133: S80-S81. DOI: 10.1016/S0167-8140(19)30585-7  0.105
2002 Matise TC, Porter CJ, Buyske S, Cuttichia AJ, Sulman EP, White PS. Systematic evaluation of map quality: human chromosome 22. American Journal of Human Genetics. 70: 1398-410. PMID 11992248 DOI: 10.1086/340605  0.104
2022 Lassman AB, Pugh SL, Wang TJC, Aldape K, Gan HK, Preusser M, Vogelbaum MA, Sulman EP, Won M, Zhang P, Moazami G, Macsai MS, Gilbert MR, Bain EE, Blot V, et al. Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial. Neuro-Oncology. PMID 35849035 DOI: 10.1093/neuonc/noac173  0.103
2012 Chakravarti A, Wang M, Aldape K, Sulman E, Bredel M, Hegi M, Gilbert M, Curran W, Werner-Wasik M, Mehta M. 431 A Revised RTOG Recursive Partitioning Analysis (RPA) Model for Glioblastoma Based Upon Multi-Platform Biomarker Profiles European Journal of Cancer. 48: 134. DOI: 10.1016/S0959-8049(12)72229-3  0.1
2020 Teruel JR, Malin M, Liu EK, McCarthy A, Hu K, Cooper BT, Sulman EP, Silverman JS, Barbee D. Full automation of spinal stereotactic radiosurgery and stereotactic body radiation therapy treatment planning using Varian Eclipse scripting. Journal of Applied Clinical Medical Physics. PMID 32965754 DOI: 10.1002/acm2.13017  0.093
2020 Wefel JS, Won M, Lassman A, Stern Y, Wang T, Aldape K, Armstrong T, Vogelbaum M, Sulman E, Moazami G, Macsai M, Gilbert M, Bain E, Blot V, Gan H, et al. CTNI-51. NEUROCOGNITIVE FUNCTION (NCF) OUTCOMES OF RTOG FOUNDATION 3508: A PHASE 3 TRIAL OF ABT-414 WITH CONCURRENT CHEMORADIATION AND ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH EGFR-AMPLIFIED NEWLY DIAGNOSED GBM Neuro-Oncology. 22: ii54-ii54. DOI: 10.1093/neuonc/noaa215.217  0.087
1997 Jensen SJ, Sulman EP, Maris JM, Matise TC, Vojta PJ, Barrett JC, Brodeur GM, White PS. An integrated transcript map of human chromosome 1p35-p36. Genomics. 42: 126-36. PMID 9177782 DOI: 10.1006/Geno.1997.4714  0.085
2018 Chung C, Brown P, Liu D, Grosshans D, Dibaj S, Guha-Thakurta N, Li J, McGovern S, McAleer M, Ghia A, Paulino A, Sulman E, Penas-Prado M, De Groot J, Heimberger A, et al. EP-1239: Ph II randomized trial comparing cognitive outcomes of proton vs. photon radiation for glioblastoma Radiotherapy and Oncology. 127: S686. DOI: 10.1016/S0167-8140(18)31549-4  0.082
2023 Sulman EP, Eisenstat DD. Editorial: 365 days of progress in neuro-oncology and neurosurgical oncology. Frontiers in Oncology. 13: 1279957. PMID 37746263 DOI: 10.3389/fonc.2023.1279957  0.075
2014 Takiar V, Burks J, Sulman E, Ramondetta L, Jhingran A, Deavers M, Eifel P, Klopp A. PD-1 Levels Correlate With Lymph Node Positivity in Patients With Squamous Cell Carcinoma of the Cervix International Journal of Radiation Oncology*Biology*Physics. 90: S479-S480. DOI: 10.1016/J.Ijrobp.2014.05.1487  0.067
2021 Byun DJ, Modrek AS, Sulman EP. Insight into the public's interest in tumour treating fields. British Journal of Cancer. PMID 34316021 DOI: 10.1038/s41416-021-01504-9  0.054
2021 Mrugala MM, Ostrom QT, Pressley SM, Taylor JW, Thomas AA, Wefel JS, Coven SL, Acquaye AA, Haynes C, Agnihotri S, Lim M, Peters KB, Sulman EP, Salcido JT, Butowski NA, et al. The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment. Neuro-Oncology Advances. 3: vdab035. PMID 34007966 DOI: 10.1093/noajnl/vdab035  0.044
2021 Modrek AS, Tanese N, Placantonakis DG, Sulman EP, Rivera R, Du KL, Gerber NK, David G, Chesler M, Philips MR, Cangiarella J. Breaking Tradition to Bridge Bench and Bedside: Accelerating the MD-PhD-Residency Pathway. Academic Medicine : Journal of the Association of American Medical Colleges. PMID 33464738 DOI: 10.1097/ACM.0000000000003920  0.032
Hide low-probability matches.